Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.31 [1.25-1.37],1.35829206618123e-29,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.84 [0.81-0.87],2.0516201191486e-21,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,2.54 [2.09-3.09],1.1836169280443e-20,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LPA,Apolipoprotein(a),Inverse variance weighted,38,1.07 [1.05-1.09],1.31589777359137e-11,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KHK,Ketohexokinase,Inverse variance weighted,22,1.09 [1.05-1.13],1.58860253770241e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.1 [1.05-1.15],2.30722164439717e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPE,Carboxypeptidase E,Inverse variance weighted,11,0.93 [0.9-0.97],0.000119248978728748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.92 [0.89-0.96],0.000257376498763515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.2 [1.08-1.32],0.00035164309536743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PARP1,Poly [ADP-ribose] polymerase 1,Wald ratio,1,0.85 [0.77-0.93],0.00053465963089627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.95 [0.92-0.98],0.000599036529583834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGRN,Agrin,Inverse variance weighted,17,0.93 [0.89-0.97],0.000647662237304382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPA1,Carboxypeptidase A1,Inverse variance weighted,2,0.86 [0.8-0.94],0.000680229877541261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.95 [0.93-0.98],0.000746103520963686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.05 [1.02-1.08],0.000935977979213954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.17 [1.06-1.28],0.00126163193900573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.2 [1.07-1.36],0.00228745696105355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,0.89 [0.83-0.96],0.00334614981633364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Inverse variance weighted,3,1.11 [1.03-1.19],0.00363318201091079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANXA10,Annexin A10,Wald ratio,1,1.45 [1.11-1.89],0.00644246437107729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,0.94 [0.9-0.98],0.00662721451037553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.12 [1.03-1.23],0.00716792173959844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.89 [0.82-0.97],0.0076398611010549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.07 [1.02-1.12],0.00772288991285867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ABL1,Tyrosine-protein kinase ABL1,Wald ratio,1,1.32 [1.07-1.62],0.00877168303556987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KITLG,Kit ligand,Wald ratio,1,0.7 [0.53-0.92],0.00914058303560443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.07 [1.02-1.13],0.00937088109023002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.94 [0.89-0.98],0.0100060278282316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRND,Prion-like protein doppel,Inverse variance weighted,9,0.95 [0.92-0.99],0.0104123206537898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1.26 [1.05-1.5],0.0108458759571938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.85 [0.75-0.97],0.0128818981273708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANG,Angiogenin,Inverse variance weighted,19,1.04 [1.01-1.07],0.0133508919486876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,0.96 [0.94-0.99],0.0135178333110327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MPO,Myeloperoxidase,Inverse variance weighted,11,1.05 [1.01-1.09],0.0135831459019724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.17 [1.03-1.33],0.013680245818134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",Wald ratio,1,1.32 [1.06-1.66],0.014616327744006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.88 [0.8-0.98],0.0146734565806949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.11 [1.02-1.2],0.0148960947278225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.97 [0.95-0.99],0.015574992547409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.47 [1.07-2.01],0.0167505351834654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.95 [0.91-0.99],0.0170526923616326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.96 [0.92-0.99],0.0176909284000778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNAP25,Synaptosomal-associated protein 25,Inverse variance weighted,2,0.86 [0.77-0.98],0.0179266684322994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.97 [0.95-1],0.0201758002927355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD248,Endosialin,Inverse variance weighted,2,1.39 [1.05-1.83],0.0202452958860972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FURIN,Furin,Wald ratio,1,1.1 [1.01-1.19],0.0204012433495898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.96 [0.93-0.99],0.0211642602275851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.04 [1.01-1.08],0.0222040071569016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.85 [0.74-0.98],0.0223259519682078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.98 [0.96-1],0.0239008614830297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,12,1.05 [1.01-1.1],0.0240912669979698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [1-1.05],0.025641871218287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LDLR,Low-density lipoprotein receptor,Wald ratio,1,1.89 [1.07-3.33],0.0271807798708654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.02 [1-1.04],0.0293616550232211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.07 [1.01-1.13],0.0301326838183513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.08 [1.01-1.16],0.0335978942490233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLMAP,Sarcolemmal membrane-associated protein,Inverse variance weighted,2,0.81 [0.66-0.98],0.0343421552285766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.11 [1.01-1.23],0.0369370864069348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,0.92 [0.84-0.99],0.037223716589352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD302,CD302 antigen,Inverse variance weighted,9,0.95 [0.91-1],0.0392291231548172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGMN,Legumain,Inverse variance weighted,12,0.96 [0.93-1],0.0394767502362385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSD,Cathepsin D,Inverse variance weighted,17,1.04 [1-1.08],0.0395471724615747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MB,Myoglobin,Wald ratio,1,1.46 [1.02-2.1],0.0400402749565405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.97 [0.94-1],0.0420027197630172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.03 [1-1.07],0.0428137281749769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.05 [1-1.09],0.0428760505659591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PEBP1,Phosphatidylethanolamine-binding protein 1,Wald ratio,1,0.84 [0.71-0.99],0.0429417153675793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,39,0.97 [0.94-1],0.0443408968725655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.94 [0.89-1],0.0445332698338123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1.21 [1-1.47],0.0462261996009395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.9 [0.81-1],0.0463524380483685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RTBDN,Retbindin,Inverse variance weighted,3,0.93 [0.86-1],0.0472935733652343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.98 [0.96-1],0.0477115837631243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.92 [0.85-1],0.0480368176225166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.04 [1-1.07],0.0481610136288909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.93 [0.86-1],0.0483223169300002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLSCR3,Phospholipid scramblase 3,Wald ratio,1,0.88 [0.77-1],0.0492289890038661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.11 [1-1.23],0.0495924882896048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SORD,Sorbitol dehydrogenase,Inverse variance weighted,3,0.93 [0.86-1],0.0496755921814304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.06 [1-1.13],0.0506860151305404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.07 [1-1.14],0.0510073658313613,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MFGE8,Lactadherin,Inverse variance weighted,11,1.05 [1-1.09],0.0516825012001403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,7,1.13 [1-1.27],0.0517457395688669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.97 [0.95-1],0.0517906739876799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.05 [1-1.11],0.0528360557958631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.18 [1-1.39],0.0533215813616739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.02 [1-1.05],0.0537355480378695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,7,1.13 [1-1.28],0.0551574177858534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,Inverse variance weighted,7,0.94 [0.88-1],0.0552999288732148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSV,Cathepsin L2,Inverse variance weighted,11,0.95 [0.9-1],0.0560003232313227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [1-1.1],0.0579259052923175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,Inverse variance weighted,27,1.03 [1-1.06],0.058454610252719,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.93 [0.86-1],0.0592217390855049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NID1,Nidogen-1,Inverse variance weighted,6,0.95 [0.91-1],0.0594483574623193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SOST,Sclerostin,Wald ratio,1,1.27 [0.99-1.63],0.0599799754084163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.05 [1-1.11],0.06065897836043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.01 [1-1.03],0.0608378561269088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.93 [0.86-1],0.0611767223709643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,THOP1,Thimet oligopeptidase,Inverse variance weighted,5,1.05 [1-1.1],0.0634537039694701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.97 [0.93-1],0.0641201516383975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.96 [0.92-1],0.0642630853184531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,0.99 [0.97-1],0.0658721753983726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.06 [1-1.13],0.0672992888925655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,8,1.05 [1-1.11],0.0693370355880711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.09 [0.99-1.21],0.0697750599523363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.21 [0.98-1.48],0.0725812809580307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.94 [0.88-1.01],0.0735715029946126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MPI,Mannose-6-phosphate isomerase,Inverse variance weighted,6,1.05 [0.99-1.11],0.0743858789066679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,20,1.03 [1-1.06],0.0745846194797589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.04 [1-1.09],0.0751904033475187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.98 [0.95-1],0.0752594485589731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOD,Apolipoprotein D,Inverse variance weighted,7,1.04 [1-1.08],0.0755757159383704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.87 [0.74-1.02],0.0768871922957393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.96 [0.92-1],0.0769863708972375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NRP2,Neuropilin-2,Inverse variance weighted,11,0.96 [0.92-1],0.0775579455341315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.05 [0.99-1.1],0.0788567803982814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SELL,L-selectin,Inverse variance weighted,18,0.97 [0.94-1],0.0805175175717521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.03 [1-1.07],0.08515825950841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDCD5,Programmed cell death protein 5,Inverse variance weighted,14,0.97 [0.93-1],0.0854962397232338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.98 [0.96-1],0.0859670388415052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.75 [0.54-1.04],0.0869673672390439,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.95 [0.9-1.01],0.0876863972758492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.97 [0.93-1],0.0905289881174638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C19orf12,Protein C19orf12,Wald ratio,1,0.74 [0.52-1.05],0.0908157573241522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.02 [1-1.03],0.0911401432838796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.05 [0.99-1.11],0.0931579450661148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RSPO3,R-spondin-3,Inverse variance weighted,6,0.94 [0.88-1.01],0.0933397406637606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.01 [1-1.03],0.0959317310557542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TARBP2,RISC-loading complex subunit TARBP2,Wald ratio,1,0.78 [0.58-1.05],0.0977957850340924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.03 [0.99-1.06],0.100076018265237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.03 [0.99-1.07],0.101400941395643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PSME1,Proteasome activator complex subunit 1,Wald ratio,1,0.88 [0.75-1.03],0.101437596039911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.97 [0.93-1.01],0.103459794397984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CNTN1,Contactin-1,Inverse variance weighted,22,0.96 [0.91-1.01],0.104335168752447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.01 [1-1.03],0.104500165349253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VWC2,Brorin,Inverse variance weighted,22,1.03 [0.99-1.08],0.104749632696952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.03 [0.99-1.07],0.107545496181003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNAJC6,Putative tyrosine-protein phosphatase auxilin,Inverse variance weighted,2,0.87 [0.74-1.03],0.10808498957875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC3B,Tetranectin,Inverse variance weighted,7,0.96 [0.9-1.01],0.109086919378929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD83,CD83 antigen,Inverse variance weighted,5,1.06 [0.99-1.13],0.112465325114344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",Inverse variance weighted,2,0.93 [0.85-1.02],0.113787821967388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.08 [0.98-1.18],0.114910376345028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOA2,Apolipoprotein A-II,Wald ratio,1,0.85 [0.69-1.04],0.115758911836324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DBI,Acyl-CoA-binding protein,Inverse variance weighted,9,0.96 [0.92-1.01],0.116828821295155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.07 [0.98-1.17],0.11684324646199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ELN,Elastin,Inverse variance weighted,2,1.15 [0.96-1.38],0.118392890945867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.06 [0.98-1.15],0.118423151086535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ICAM4,Intercellular adhesion molecule 4,Inverse variance weighted,3,0.91 [0.81-1.02],0.118992021418147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.98 [0.96-1.01],0.120571395891948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [1-1.04],0.121299355401158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,32,1.02 [0.99-1.05],0.122218967544743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.93 [0.85-1.02],0.122366242702246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLGN,Calmegin,Inverse variance weighted,23,0.98 [0.96-1],0.122454917506144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.9 [0.78-1.03],0.124415784377432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.04 [0.99-1.09],0.126139617346508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRP,Gastrin-releasing peptide,Inverse variance weighted,12,1.02 [0.99-1.05],0.126716974306663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.97 [0.94-1.01],0.1290669078179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.97 [0.93-1.01],0.129262066842016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.02 [0.99-1.05],0.129910612865524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PVR,Poliovirus receptor,Inverse variance weighted,27,1.02 [0.99-1.05],0.130135755399529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.98 [0.95-1.01],0.130442270189849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.05 [0.99-1.12],0.131374426612605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PENK,Proenkephalin-A,Inverse variance weighted,19,1.03 [0.99-1.07],0.132390927219003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.96 [0.92-1.01],0.132570359522602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.97 [0.94-1.01],0.137013860454651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNCA,Alpha-synuclein,Wald ratio,1,0.79 [0.58-1.08],0.137541507911445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,22,0.98 [0.96-1.01],0.13817431119211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.02 [0.99-1.04],0.138492987686677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.15 [0.96-1.38],0.140070385813351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.97 [0.93-1.01],0.140302998035244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.05 [0.99-1.11],0.140447156974257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPB1,Carboxypeptidase B,Wald ratio,1,1.1 [0.97-1.24],0.143682385246082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGSF9,Protein turtle homolog A,Inverse variance weighted,10,0.97 [0.93-1.01],0.144123509155234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.04 [0.99-1.09],0.144443816708709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL15,Interleukin-15,Wald ratio,1,2.53 [0.72-8.87],0.14557299746024,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.96-1.01],0.145823053218351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.04 [0.99-1.09],0.146118087763754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.08 [0.97-1.21],0.150342342915062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.96 [0.92-1.01],0.151714305436828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.09 [0.97-1.23],0.151927721238138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.16 [0.95-1.42],0.152133429865117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,11,1.04 [0.99-1.1],0.153130467332046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.91 [0.8-1.04],0.15358797162082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C5,Complement C5,Inverse variance weighted,3,1.06 [0.98-1.16],0.15370549662605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.04 [0.99-1.09],0.155084630560071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.09 [0.97-1.22],0.155151128620321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS8,Galectin-8,Inverse variance weighted,7,0.96 [0.9-1.02],0.156993148207646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,10,1.04 [0.98-1.11],0.157641156041484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.96 [0.9-1.02],0.1583935914531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MSLN,Mesothelin,Inverse variance weighted,25,1.02 [0.99-1.04],0.158650906642273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.98 [0.96-1.01],0.15865334593094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.97 [0.94-1.01],0.158715384587214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.97 [0.92-1.01],0.160525846684566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.06 [0.98-1.14],0.161389671353221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.01 [0.99-1.04],0.162693275978072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.8 [0.58-1.1],0.163117432200218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.98 [0.95-1.01],0.167457743591356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.97 [0.93-1.01],0.167592655021489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OCLN,Occludin,Inverse variance weighted,2,1.08 [0.97-1.21],0.169819524911018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.98 [0.94-1.01],0.170484283485159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MEP1A,Meprin A subunit alpha,Inverse variance weighted,8,0.97 [0.92-1.02],0.171490931620685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCL2,Apoptosis regulator Bcl-2,Inverse variance weighted,2,1.17 [0.93-1.46],0.172180005112695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,0.98 [0.95-1.01],0.172940959473959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.96 [0.91-1.02],0.173769447603529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL10,Interleukin-10,Wald ratio,1,0.91 [0.8-1.04],0.17430554360109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP3,Stromelysin-1,Inverse variance weighted,34,1.02 [0.99-1.05],0.174772565760615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPON2,Spondin-2,Inverse variance weighted,4,0.96 [0.91-1.02],0.175613836216304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.97 [0.92-1.02],0.17784587601369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PROC,Vitamin K-dependent protein C,Inverse variance weighted,4,0.86 [0.7-1.07],0.178293793266855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1.18 [0.93-1.49],0.179049022789236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.03 [0.99-1.07],0.180424631741157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.04 [0.98-1.11],0.181097388991026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AP3B1,AP-3 complex subunit beta-1,Wald ratio,1,0.81 [0.6-1.1],0.181622239003824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.24 [0.9-1.7],0.182103779038256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CNTN5,Contactin-5,Inverse variance weighted,28,1.02 [0.99-1.05],0.185168257276672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNAP29,Synaptosomal-associated protein 29,Wald ratio,1,1.16 [0.93-1.43],0.185442083301575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TCOF1,Treacle protein,Wald ratio,1,0.84 [0.64-1.09],0.185914264097511,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.87 [0.7-1.07],0.187583413905549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,1.04 [0.98-1.09],0.188895996255458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.06 [0.97-1.16],0.192208545044765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,21,0.98 [0.94-1.01],0.192349100270403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGA2,Integrin alpha-2,Inverse variance weighted,31,1.02 [0.99-1.05],0.198230601341667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.95 [0.88-1.03],0.198879475326591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.04 [0.98-1.1],0.198976394657367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.03 [0.98-1.08],0.199299263432111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.03 [0.99-1.07],0.200061798530536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1.06 [0.97-1.16],0.200221991880299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.84 [0.64-1.1],0.200306244759784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTSL5,ADAMTS-like protein 5,Inverse variance weighted,15,0.98 [0.95-1.01],0.202180796316838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HPSE,Heparanase,Wald ratio,1,0.97 [0.92-1.02],0.20281423337741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.03 [0.99-1.07],0.203919936875418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.08 [0.96-1.22],0.203948905339347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,1.05 [0.97-1.13],0.204001353485368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SELE,E-selectin,Inverse variance weighted,4,0.92 [0.81-1.05],0.204273890704949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN5,CCN family member 5,Inverse variance weighted,8,1.07 [0.96-1.19],0.205272254978132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.29 [0.87-1.91],0.20626778768729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,1.21 [0.9-1.64],0.208018089695385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.02 [0.99-1.05],0.20842386521163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFH,Complement factor H,Inverse variance weighted,19,0.98 [0.94-1.01],0.208472055280401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.04 [0.98-1.11],0.210334101762248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NIT2,Omega-amidase NIT2,Inverse variance weighted,3,0.9 [0.75-1.06],0.210792022194737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,0.97 [0.93-1.02],0.212471408142164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.03 [0.98-1.09],0.213043744674539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.08 [0.96-1.22],0.213411474445503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK14,Kallikrein-14,Inverse variance weighted,15,1.02 [0.99-1.05],0.215683824492353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.99 [0.98-1],0.216276599195085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.02 [0.99-1.06],0.216460046149533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.94 [0.86-1.04],0.218673724107718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FBLN2,Fibulin-2,Inverse variance weighted,11,1.03 [0.99-1.07],0.22082978442905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.94 [0.86-1.03],0.221236505993051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NRP1,Neuropilin-1,Inverse variance weighted,12,0.98 [0.94-1.01],0.222933478031548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.98 [0.94-1.01],0.227072112264704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD36,Platelet glycoprotein 4,Inverse variance weighted,5,1.03 [0.98-1.07],0.227755382743054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.96 [0.89-1.03],0.232518678459742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.07 [0.96-1.2],0.236004068745451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.95 [0.87-1.03],0.236677738065164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.94 [0.85-1.04],0.237784795481551,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.1 [0.94-1.3],0.238656364024478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.95 [0.88-1.03],0.240961728080173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.98 [0.94-1.02],0.243943324445512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.91 [0.77-1.07],0.244846150632309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINH1,Serpin H1,Inverse variance weighted,3,1.09 [0.94-1.27],0.247465958165081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.99 [0.97-1.01],0.248209336775324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,1.04 [0.97-1.11],0.249780713885654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHAD,Chondroadherin,Inverse variance weighted,3,1.02 [0.98-1.07],0.250309799423254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.95 [0.88-1.03],0.250361272502839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,31,0.98 [0.95-1.01],0.251856138317842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,1.04 [0.97-1.1],0.256925212044588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP7,Matrilysin,Inverse variance weighted,13,1.02 [0.98-1.07],0.257628903320826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,0.94 [0.84-1.05],0.258071483952153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP10,Stromelysin-2,Inverse variance weighted,22,0.98 [0.95-1.01],0.258282064521101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDH3,Cadherin-3,Inverse variance weighted,2,0.91 [0.78-1.07],0.26099623968641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.99 [0.98-1.01],0.262914759629249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.08 [0.94-1.24],0.263718162502343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.03 [0.98-1.08],0.264698412423663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.17 [0.89-1.54],0.264710094215405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.98 [0.95-1.02],0.266249654966167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,0.85 [0.63-1.14],0.267506169994257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.07 [0.95-1.22],0.268915896244993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS1,Galectin-1,Inverse variance weighted,6,1.02 [0.98-1.06],0.27202232496424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL19,Interleukin-19,Inverse variance weighted,11,1.03 [0.98-1.08],0.274033685276365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.98 [0.93-1.02],0.274526892548739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.89 [0.71-1.1],0.275481158130967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.93 [0.82-1.06],0.275586191915792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.97 [0.93-1.02],0.276424533042955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.02 [0.99-1.05],0.27643363133396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.98 [0.94-1.02],0.277734938549306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,0.99 [0.96-1.01],0.282908316470417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.12 [0.91-1.39],0.287579202753424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPON1,Spondin-1,Inverse variance weighted,21,0.98 [0.94-1.02],0.289923924015767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.04 [0.97-1.12],0.289933633691966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",Inverse variance weighted,2,1.05 [0.96-1.14],0.29041642339138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD27,CD27 antigen,Inverse variance weighted,9,0.98 [0.94-1.02],0.291963070188326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,1.06 [0.95-1.17],0.295009222058976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,0.96 [0.89-1.04],0.297207632774475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.89 [0.72-1.11],0.297219653340221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAT,Linker for activation of T-cells family member 1,Wald ratio,1,1.19 [0.86-1.64],0.299120045750276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.14 [0.89-1.47],0.299721441554313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.97 [0.92-1.03],0.299735434288861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHGA,Chromogranin-A,Inverse variance weighted,3,1.06 [0.95-1.19],0.300808879658912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1.07 [0.94-1.23],0.302555434451424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.02 [0.99-1.05],0.304272049724772,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.96 [0.89-1.04],0.304474515002411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.04 [0.97-1.11],0.305154299077434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.97 [0.91-1.03],0.305185846791374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSF,Cathepsin F,Inverse variance weighted,10,1.03 [0.97-1.09],0.306601461934641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STAB2,Stabilin-2,Inverse variance weighted,20,0.99 [0.96-1.01],0.307951888977339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.97 [0.9-1.03],0.308042858481385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,1.01 [0.99-1.04],0.311921186178685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.95 [0.87-1.05],0.312596174612258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,1.02 [0.98-1.08],0.313836194577588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.01 [0.99-1.02],0.314099035537265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.02 [0.98-1.06],0.315214138357007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.83 [0.58-1.19],0.316099349704915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.13 [0.89-1.42],0.316313245993297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.17 [0.86-1.61],0.317133333127357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.97-1.01],0.318139955367206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.05 [0.95-1.15],0.319189196021512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCG2,Secretogranin-2,Wald ratio,1,1.16 [0.87-1.54],0.321863332696412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1.06 [0.95-1.18],0.322124838549653,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GOT1,"Aspartate aminotransferase, cytoplasmic",Wald ratio,1,1.18 [0.85-1.66],0.323520702745817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.99 [0.97-1.01],0.324307116387589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,Wald ratio,1,0.86 [0.64-1.16],0.32560123403497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.96 [0.89-1.04],0.326386886324241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AREG,Amphiregulin,Inverse variance weighted,3,0.93 [0.81-1.07],0.327363510559999,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN3,CCN family member 3,Inverse variance weighted,19,1.02 [0.98-1.06],0.3292811563691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.03 [0.97-1.08],0.330188848936691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.02 [0.98-1.06],0.330622243539514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.08 [0.92-1.27],0.331181129424858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.18 [0.85-1.63],0.331329876445175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.16 [0.86-1.56],0.334373446187549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.88 [0.69-1.14],0.335625019246079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNX15,Sorting nexin-15,Inverse variance weighted,13,1.02 [0.98-1.05],0.339199152909048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFHR2,Complement factor H-related protein 2,Inverse variance weighted,63,1.01 [0.99-1.02],0.339774030108592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1.04 [0.96-1.14],0.339842324696726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GUCA2A,Guanylin,Inverse variance weighted,9,0.97 [0.91-1.03],0.339858211627675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1.01 [0.99-1.04],0.342286812074931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.98 [0.95-1.02],0.34586089428847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,QDPR,Dihydropteridine reductase,Inverse variance weighted,8,1.03 [0.97-1.11],0.34638509820869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP1,Interstitial collagenase,Inverse variance weighted,31,0.99 [0.96-1.01],0.346399016286689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.97 [0.92-1.03],0.346620408097422,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.02 [0.98-1.07],0.34737045319357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,1.02 [0.98-1.05],0.349004877352093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CNTN3,Contactin-3,Inverse variance weighted,14,0.98 [0.95-1.02],0.350196187274287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EZR,Ezrin,Wald ratio,1,0.89 [0.69-1.14],0.352521843046205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,23,1.01 [0.98-1.05],0.354126610313257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.01 [0.99-1.03],0.358059737102402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MYDGF,Myeloid-derived growth factor,Wald ratio,1,0.91 [0.75-1.11],0.358141656116975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.99 [0.97-1.01],0.35896288919017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IFNL1,Interferon lambda-1,Wald ratio,1,1.16 [0.85-1.58],0.359903499746762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.04 [0.95-1.14],0.360876915102963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.04 [0.96-1.13],0.361802243097748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.06 [0.93-1.22],0.362224920242713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPB2,Carboxypeptidase B2,Inverse variance weighted,27,1.02 [0.98-1.05],0.362802973971709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.02 [0.98-1.06],0.363655811296009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPP1,Osteopontin,Inverse variance weighted,8,0.96 [0.87-1.05],0.363937486486191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.98-1.01],0.364487144798675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.06 [0.94-1.19],0.36561796420599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.05 [0.94-1.18],0.366826707447227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ASAH1,Acid ceramidase,Inverse variance weighted,20,1.01 [0.99-1.03],0.366835066204533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,1.01 [0.98-1.05],0.368477175395307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,0.98 [0.95-1.02],0.368693768210417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.98 [0.94-1.03],0.376172017693467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,11,0.98 [0.94-1.03],0.376317913554412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.05 [0.95-1.16],0.376739963137046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.98 [0.94-1.02],0.379242971467826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,POMC,Pro-opiomelanocortin,Inverse variance weighted,2,0.93 [0.8-1.09],0.379749353745211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.07 [0.92-1.23],0.381633623323749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.98 [0.93-1.03],0.381948107563791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.11 [0.88-1.39],0.381997030572045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PKD1,Polycystin-1,Inverse variance weighted,12,1.02 [0.97-1.08],0.382801659591592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.01 [0.99-1.03],0.384729513885716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RETN,Resistin,Inverse variance weighted,9,0.99 [0.96-1.02],0.390403323641639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TP53I3,Quinone oxidoreductase PIG3,Inverse variance weighted,17,0.99 [0.96-1.02],0.395276517144145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,1.19 [0.79-1.8],0.397023326458246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PGF,Placenta growth factor,Inverse variance weighted,2,0.8 [0.47-1.35],0.397699123510583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CST7,Cystatin-F,Inverse variance weighted,39,0.99 [0.97-1.01],0.39974016776175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP6,Gastrotropin,Wald ratio,1,0.96 [0.86-1.06],0.400176091869105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TALDO1,Transaldolase,Inverse variance weighted,3,1.06 [0.93-1.21],0.400424003251119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,Wald ratio,1,0.92 [0.75-1.12],0.401153661735436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.02 [0.97-1.07],0.401501028988194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,XCL1,Lymphotactin,Inverse variance weighted,31,0.99 [0.97-1.01],0.402231946931256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.96 [0.88-1.05],0.403429269714918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.03 [0.97-1.09],0.404153305451693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.03 [0.96-1.11],0.404507582210742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.99 [0.97-1.01],0.405689600667496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,6,0.97 [0.91-1.04],0.406974501338746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN2,CCN family member 2,Inverse variance weighted,9,1.02 [0.98-1.06],0.408844685475588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.99 [0.97-1.01],0.409556233408487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRSS8,Prostasin,Inverse variance weighted,5,1.04 [0.95-1.15],0.409641750734419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,1.01 [0.98-1.05],0.409719121022918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.06 [0.93-1.2],0.410883164119023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.92 [0.77-1.12],0.413158176923023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNX9,Sorting nexin-9,Inverse variance weighted,3,1.1 [0.87-1.39],0.413324618714549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.04 [0.95-1.13],0.413377919140388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.98 [0.94-1.03],0.41401216215565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGA5,Integrin alpha-5,Wald ratio,1,0.91 [0.72-1.14],0.414532672826949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCHE,Cholinesterase,Inverse variance weighted,30,0.99 [0.96-1.02],0.416780614433162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.03 [0.96-1.11],0.422561747606207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.02 [0.98-1.05],0.422802254634579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FUOM,Fucose mutarotase,Inverse variance weighted,3,0.95 [0.84-1.08],0.423990753367699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LONP1,"Lon protease homolog, mitochondrial",Inverse variance weighted,3,0.97 [0.9-1.04],0.428508781860886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.01 [0.99-1.02],0.429193769308192,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SDC4,Syndecan-4,Inverse variance weighted,8,0.97 [0.9-1.05],0.429548584293749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.95-1.02],0.430888874858951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.02 [0.97-1.07],0.432514543370449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.98 [0.92-1.04],0.433984021650527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.99 [0.96-1.02],0.4365807397258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNPEP,Aspartyl aminopeptidase,Inverse variance weighted,2,0.85 [0.56-1.29],0.43783763633625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.01 [0.99-1.03],0.438733074126639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.04 [0.95-1.13],0.439129600339107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,Inverse variance weighted,3,1.06 [0.92-1.21],0.439598423270918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.96 [0.87-1.06],0.441473379141609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TCTN3,Tectonic-3,Inverse variance weighted,33,1.01 [0.99-1.03],0.444163608111265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.97 [0.89-1.05],0.444546383881212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.95 [0.83-1.08],0.445489901454504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,14,1.01 [0.98-1.05],0.449371110756199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL17C,Interleukin-17C,Inverse variance weighted,3,1.04 [0.94-1.15],0.450059767025606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINB8,Serpin B8,Inverse variance weighted,28,0.99 [0.98-1.01],0.45324279130098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.78 [0.4-1.51],0.45424980985541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,0.94 [0.81-1.1],0.454504529151851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.98 [0.94-1.03],0.458325719523471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TOP2B,DNA topoisomerase 2-beta,Wald ratio,1,0.94 [0.79-1.11],0.458908313531755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,1.07 [0.89-1.29],0.45939382452564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KYNU,Kynureninase,Inverse variance weighted,8,1.02 [0.96-1.09],0.461801137461347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,0.96 [0.85-1.08],0.463346753413008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.02 [0.97-1.07],0.464004816133074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PALM,Paralemmin-1,Inverse variance weighted,6,1.03 [0.95-1.12],0.466073730184057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.01 [0.98-1.04],0.467246014440485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.01 [0.98-1.04],0.467480626923686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FCN1,Ficolin-1,Inverse variance weighted,28,0.99 [0.96-1.02],0.468982406594204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.02 [0.97-1.08],0.469023442170815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,42,1.01 [0.99-1.03],0.470087566300437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,S100P,Protein S100-P,Inverse variance weighted,2,0.93 [0.78-1.12],0.470336890243968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.95 [0.84-1.09],0.472017704993978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.94 [0.79-1.12],0.472209953246841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLG,Plasminogen,Inverse variance weighted,20,1.02 [0.96-1.09],0.472341093731168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,3,0.97 [0.9-1.05],0.473433088871344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,0.99 [0.98-1.01],0.477725863789747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OPLAH,5-oxoprolinase,Inverse variance weighted,4,1.02 [0.96-1.09],0.480633486958525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TIMP3,Metalloproteinase inhibitor 3,Inverse variance weighted,23,1.01 [0.98-1.03],0.480887652172254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MBL2,Mannose-binding protein C,Inverse variance weighted,40,0.99 [0.97-1.01],0.482661381646197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.04 [0.93-1.15],0.482907595016894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MME,Neprilysin,Inverse variance weighted,3,0.92 [0.73-1.16],0.483913142787878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.95 [0.83-1.09],0.487078505150535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.02 [0.97-1.06],0.490031676566933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,0.98 [0.92-1.04],0.490449353766941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GLO1,Lactoylglutathione lyase,Inverse variance weighted,13,0.99 [0.95-1.03],0.492188509986001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.91 [0.7-1.19],0.492639304148381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1.01 [0.99-1.02],0.492950786283267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.99 [0.95-1.02],0.493425416391398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BSG,Basigin,Wald ratio,1,1.03 [0.94-1.14],0.493892746210729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,1.01 [0.98-1.04],0.494344261698015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.97 [0.88-1.06],0.495221666576981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.01 [0.98-1.04],0.501184308776033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.04 [0.94-1.15],0.501861329743731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK4,Kallikrein-4,Inverse variance weighted,17,0.99 [0.96-1.02],0.504357589713967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.98 [0.93-1.04],0.505454402563287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.03 [0.94-1.13],0.505476031798114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.98 [0.94-1.03],0.50621223585911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REN,Renin,Inverse variance weighted,4,1.02 [0.97-1.07],0.508334844689927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.01 [0.98-1.05],0.509881378363554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSO,Cathepsin O,Inverse variance weighted,6,0.98 [0.92-1.04],0.512675470656264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS9,Galectin-9,Inverse variance weighted,26,0.99 [0.96-1.02],0.512910592633865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.99 [0.96-1.02],0.51301290823488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.06 [0.9-1.24],0.513768063741391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.99 [0.96-1.02],0.514081093773304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,UMOD,Uromodulin,Inverse variance weighted,29,1.01 [0.99-1.02],0.514254683398545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.99-1.03],0.51502840960488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.04 [0.93-1.16],0.516026028819929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,1.07 [0.87-1.31],0.517281951778114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.07 [0.87-1.32],0.51851972007668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PALM2,Paralemmin-2,Inverse variance weighted,8,1.02 [0.96-1.08],0.522557290633745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,0.99 [0.97-1.01],0.523583240296812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NFASC,Neurofascin,Inverse variance weighted,15,0.99 [0.95-1.03],0.524036432413631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.96-1.08],0.525384382801994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFI,Complement factor I,Inverse variance weighted,6,1.02 [0.96-1.08],0.526442230602906,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.03 [0.95-1.11],0.528497215769916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHMP6,Charged multivesicular body protein 6,Wald ratio,1,0.98 [0.9-1.05],0.528681131059712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,0.97 [0.88-1.07],0.530604933505845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALB1,Calbindin,Inverse variance weighted,2,0.95 [0.81-1.11],0.532682003245851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRSS2,Trypsin-2,Inverse variance weighted,3,0.95 [0.81-1.12],0.53403345010583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TDRKH,Tudor and KH domain-containing protein,Inverse variance weighted,8,1.03 [0.94-1.13],0.534261356952954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AMBP,Protein AMBP,Inverse variance weighted,3,1.04 [0.91-1.19],0.536234866808442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTN,Pleiotrophin,Inverse variance weighted,4,1.04 [0.91-1.19],0.537048348305321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,4,1.04 [0.93-1.16],0.537098769000876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,0.99 [0.96-1.02],0.537404481795289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.9 [0.65-1.26],0.539422639268277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGFLAM,Pikachurin,Inverse variance weighted,19,0.99 [0.97-1.02],0.539440675085299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD209,CD209 antigen,Inverse variance weighted,15,0.98 [0.93-1.04],0.543000069945939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.01 [0.98-1.03],0.543655888197988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",Wald ratio,1,1.07 [0.86-1.34],0.543780988554675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.98 [0.94-1.04],0.544944742825212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SDC1,Syndecan-1,Inverse variance weighted,2,0.92 [0.71-1.19],0.545196385369934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.99 [0.95-1.03],0.545299612167396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.05 [0.89-1.24],0.546501163689148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNN,Tenascin-N,Inverse variance weighted,44,1.01 [0.99-1.02],0.547783171457098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STC2,Stanniocalcin-2,Inverse variance weighted,3,1.05 [0.9-1.21],0.548514730776966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,0.98 [0.91-1.05],0.550186932598314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.82 [0.42-1.59],0.550586304389064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK11,Kallikrein-11,Inverse variance weighted,6,1.01 [0.97-1.05],0.551183340087689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DSC2,Desmocollin-2,Inverse variance weighted,9,0.99 [0.94-1.03],0.551815941271166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.01 [0.98-1.04],0.553239448592842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.02 [0.96-1.09],0.553707110048874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.99 [0.97-1.02],0.558728410683128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.05 [0.88-1.26],0.559564839510942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.99 [0.95-1.03],0.560277557434946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ALCAM,CD166 antigen,Inverse variance weighted,6,0.97 [0.89-1.06],0.562193053773777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.02 [0.96-1.08],0.56258495244867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EDN1,Endothelin-1,Inverse variance weighted,3,1.03 [0.93-1.14],0.563935855611688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINB6,Serpin B6,Inverse variance weighted,4,1.02 [0.96-1.08],0.564267543749615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.01 [0.98-1.03],0.564885611087252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.9 [0.61-1.3],0.564914612907796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,1.03 [0.92-1.16],0.56539576093861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MENT,Protein MENT,Inverse variance weighted,3,1.01 [0.97-1.06],0.573517360610335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SORT1,Sortilin,Inverse variance weighted,3,0.86 [0.5-1.47],0.573680273865294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.02 [0.95-1.09],0.574599859829824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.01 [0.98-1.04],0.574901214077787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.95-1.03],0.574934850406956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRISP3,Cysteine-rich secretory protein 3,Inverse variance weighted,41,1.01 [0.99-1.03],0.57521926024919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HEPACAM2,HEPACAM family member 2,Wald ratio,1,0.82 [0.4-1.66],0.575361712243807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,0.98 [0.91-1.05],0.576329935433555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.97-1.02],0.578534476752596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,10,0.99 [0.94-1.03],0.578561103454481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.01 [0.96-1.07],0.57865122719441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.98 [0.91-1.05],0.580250631227985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.03 [0.93-1.14],0.580261725232958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.09 [0.81-1.46],0.5806646715245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NOMO1,Nodal modulator 1,Inverse variance weighted,2,0.98 [0.9-1.06],0.580988862186723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.99 [0.95-1.03],0.581803895755289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,11,1.01 [0.97-1.06],0.582145796969876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSB,Cathepsin B,Inverse variance weighted,26,1.01 [0.98-1.03],0.582945290903556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.01 [0.98-1.05],0.583499720406641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCAN,Brevican core protein,Inverse variance weighted,3,1.02 [0.96-1.08],0.584381471525504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALB2,Calretinin,Wald ratio,1,0.94 [0.75-1.17],0.584979543659413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.9 [0.6-1.33],0.585227644219928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.02 [0.95-1.11],0.585577330018433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.98 [0.91-1.06],0.586064708409417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN1,CCN family member 1,Inverse variance weighted,2,0.97 [0.86-1.09],0.587354672980421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.98 [0.92-1.05],0.588101691888051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NT5E,5'-nucleotidase,Inverse variance weighted,45,1.01 [0.99-1.02],0.592222065461004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,30,0.99 [0.97-1.01],0.594232144019662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC1B,C-type lectin domain family 1 member B,Inverse variance weighted,2,0.97 [0.89-1.07],0.595487206650632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.01 [0.97-1.05],0.596495781714434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,17,0.99 [0.96-1.03],0.597900977669782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.96 [0.81-1.13],0.600422709321662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNAJB14,DnaJ homolog subfamily B member 14,Wald ratio,1,0.93 [0.71-1.22],0.60149462196527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.99 [0.97-1.02],0.602521681533403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MVK,Mevalonate kinase,Inverse variance weighted,2,0.95 [0.77-1.17],0.603659116523002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.96 [0.81-1.13],0.604062244977969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.99 [0.95-1.03],0.605228387013265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.99 [0.95-1.03],0.605670937132075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.99 [0.97-1.02],0.605947667581309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.03 [0.92-1.16],0.606766887778649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHGB,Secretogranin-1,Inverse variance weighted,27,0.99 [0.97-1.02],0.607454840046871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SAMD9L,Sterile alpha motif domain-containing protein 9-like,Inverse variance weighted,6,0.99 [0.93-1.04],0.609347861887764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.97 [0.88-1.08],0.617238731028077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSS,Cathepsin S,Inverse variance weighted,23,1.01 [0.98-1.03],0.618211984979617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.97 [0.86-1.1],0.621989452913143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.01 [0.97-1.06],0.623702569152942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK8,Kallikrein-8,Inverse variance weighted,12,1.01 [0.97-1.05],0.623765159712004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS3,Galectin-3,Inverse variance weighted,25,0.99 [0.97-1.02],0.626470343369907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINA4,Kallistatin,Inverse variance weighted,26,1 [0.98-1.03],0.629625634986607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.99 [0.95-1.03],0.631048973228635,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STX8,Syntaxin-8,Wald ratio,1,0.96 [0.82-1.13],0.631299478189171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.01 [0.98-1.03],0.633147898374175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRN,Progranulin,Inverse variance weighted,7,0.99 [0.95-1.03],0.633820984763333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,0.99 [0.93-1.04],0.636457954784431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,Inverse variance weighted,2,1.05 [0.87-1.26],0.641879664719874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,Inverse variance weighted,2,1.04 [0.87-1.26],0.641945942252986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,F7,Coagulation factor VII,Inverse variance weighted,21,1.01 [0.97-1.04],0.644535476921616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1 [0.98-1.01],0.644766054245393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OGN,Mimecan,Inverse variance weighted,30,0.99 [0.97-1.02],0.646418043936571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.01 [0.98-1.03],0.649375180511315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEP20,Centrosomal protein 20,Inverse variance weighted,2,1.04 [0.87-1.25],0.649708665672286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.99 [0.97-1.02],0.65051515218873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,6,0.99 [0.93-1.05],0.651391162309618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.01 [0.96-1.07],0.651676610755443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PI3,Elafin,Inverse variance weighted,10,1.01 [0.96-1.07],0.652825510843761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,0.95 [0.76-1.18],0.653634179116799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CREG1,Protein CREG1,Inverse variance weighted,3,0.98 [0.91-1.06],0.654424095170054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.92 [0.62-1.35],0.655160071008122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.02 [0.93-1.12],0.655307941167162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,26,0.99 [0.93-1.05],0.655723631608447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.01 [0.98-1.04],0.658183448999159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FETUB,Fetuin-B,Inverse variance weighted,20,0.99 [0.96-1.03],0.662487312172107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.99 [0.97-1.02],0.663969380969919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.03 [0.89-1.2],0.665158065176213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,Inverse variance weighted,17,1.01 [0.96-1.07],0.666109473575741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1 [0.98-1.03],0.667056273937034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.01 [0.97-1.06],0.667070739127508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,0.96 [0.79-1.16],0.668127846806229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.01 [0.97-1.05],0.668227996709652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LCN15,Lipocalin-15,Inverse variance weighted,20,1 [0.97-1.02],0.670429947252205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.03 [0.91-1.17],0.670728275811289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.99 [0.93-1.05],0.673117261108328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDH2,Cadherin-2,Inverse variance weighted,3,0.97 [0.84-1.12],0.674177533010899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1 [0.98-1.02],0.674967253804473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPXM1,Probable carboxypeptidase X1,Inverse variance weighted,9,1.01 [0.97-1.04],0.675458442421778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGR,Tyrosine-protein kinase Fgr,Inverse variance weighted,2,1.03 [0.9-1.18],0.67787533248752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDKN1A,Cyclin-dependent kinase inhibitor 1,Inverse variance weighted,3,1.02 [0.93-1.11],0.677935108370956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.99 [0.97-1.02],0.679356778606748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRELP,Prolargin,Inverse variance weighted,9,0.99 [0.95-1.04],0.679581549670829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.99 [0.93-1.05],0.679941067536663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PGA4,Pepsin A-4,Inverse variance weighted,2,1.05 [0.83-1.33],0.680342136493855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PROK1,Prokineticin-1,Inverse variance weighted,25,0.99 [0.95-1.04],0.683435525715889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.02 [0.92-1.13],0.683990101446605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,8,0.99 [0.95-1.04],0.684279312301395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.08 [0.75-1.56],0.688169703858954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CES1,Liver carboxylesterase 1,Inverse variance weighted,15,0.99 [0.96-1.03],0.691928141715384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PSAP,Prosaposin,Inverse variance weighted,5,0.98 [0.9-1.07],0.692378981738727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.97 [0.85-1.11],0.692400601893147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DPT,Dermatopontin,Inverse variance weighted,21,0.99 [0.96-1.03],0.695347982538164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,Inverse variance weighted,2,0.95 [0.73-1.23],0.695402777741726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.03 [0.9-1.17],0.695437473792153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.99 [0.93-1.05],0.695583386210562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.99 [0.96-1.03],0.696032315885707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.93 [0.66-1.31],0.69677808325129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,19,1 [0.99-1.02],0.700802058395649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CST3,Cystatin-C,Inverse variance weighted,10,0.99 [0.95-1.03],0.706015479700432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.02 [0.92-1.13],0.706087915416412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.99 [0.94-1.04],0.709335630238177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.01 [0.96-1.07],0.709585838211629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD46,Membrane cofactor protein,Wald ratio,1,1.03 [0.88-1.2],0.710056586566849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLAT,Tissue-type plasminogen activator,Wald ratio,1,0.95 [0.73-1.24],0.710476477272925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.02 [0.9-1.17],0.713620952599839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.02 [0.91-1.14],0.716002299326271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDH1,Cadherin-1,Wald ratio,1,1.06 [0.79-1.41],0.717458365930459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1 [0.98-1.02],0.719592657584249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Wald ratio,1,0.95 [0.72-1.25],0.721319987524643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.02 [0.92-1.13],0.721509197677767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,0.99 [0.97-1.02],0.722236061946964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.94 [0.65-1.35],0.722384974713518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,1 [0.98-1.02],0.726705189490699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.03 [0.86-1.23],0.726718002557739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PYY,Peptide YY,Inverse variance weighted,6,0.99 [0.93-1.05],0.72854276222738,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.98 [0.87-1.11],0.730069483002806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1 [0.98-1.03],0.730704733948384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDHR2,Cadherin-related family member 2,Inverse variance weighted,2,0.96 [0.75-1.22],0.730716154620258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSL,Cathepsin L1,Wald ratio,1,1.05 [0.78-1.41],0.732067595729059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPPC,C-type natriuretic peptide,Wald ratio,1,0.94 [0.68-1.31],0.732321371142213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NECTIN4,Nectin-4,Inverse variance weighted,7,1.01 [0.97-1.05],0.732867310478768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,12,1 [0.98-1.03],0.733849676511743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.01 [0.95-1.07],0.734478116293595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,1.05 [0.8-1.37],0.739170081086865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NECTIN2,Nectin-2,Inverse variance weighted,5,0.97 [0.83-1.14],0.73958791618368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.01 [0.97-1.04],0.741586625338985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,1 [0.97-1.02],0.741824999475091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.03 [0.88-1.19],0.743878153204744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.06 [0.74-1.51],0.743949213365949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.99 [0.9-1.08],0.744240691127458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,43,1 [0.97-1.02],0.746290327051371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1 [0.97-1.02],0.746846085241974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1 [0.97-1.02],0.747124539963165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCAMP3,Secretory carrier-associated membrane protein 3,Wald ratio,1,1.03 [0.86-1.23],0.747365090050085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.02 [0.91-1.14],0.747748433015596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MATN2,Matrilin-2,Inverse variance weighted,18,1.01 [0.96-1.06],0.748160867284853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.01 [0.97-1.04],0.750473241971094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TMSB10,Thymosin beta-10,Wald ratio,1,1.04 [0.82-1.31],0.751037278755525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1 [0.97-1.04],0.753392759291324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.98-1.03],0.754801921919555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MUC13,Mucin-13,Inverse variance weighted,9,0.99 [0.94-1.05],0.757645133338774,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANXA2,Annexin A2,Inverse variance weighted,20,1 [0.97-1.02],0.758293293702541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLIN3,Perilipin-3,Wald ratio,1,0.97 [0.8-1.17],0.759672490025254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK10,Kallikrein-10,Inverse variance weighted,15,0.99 [0.96-1.03],0.762241766281727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AP1G2,AP-1 complex subunit gamma-like 2,Inverse variance weighted,4,1.01 [0.95-1.08],0.762736493351324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.98 [0.86-1.11],0.763936371459991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,0.98 [0.88-1.1],0.765277630476314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.98 [0.89-1.09],0.766570277392382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.01 [0.95-1.07],0.766715976867183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1 [0.98-1.02],0.768330687982802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.99 [0.93-1.06],0.771897060540035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEPTIN8,Septin-8,Inverse variance weighted,2,1.01 [0.92-1.12],0.774035559998521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GSN,Gelsolin,Inverse variance weighted,5,0.98 [0.87-1.11],0.775306677887669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.01 [0.96-1.05],0.777292464031851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,10,0.99 [0.95-1.04],0.779226120231123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,S100A11,Protein S100-A11,Wald ratio,1,0.99 [0.9-1.08],0.780822765501424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.98 [0.82-1.16],0.781797633562816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.02 [0.88-1.18],0.781829778643392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL8,Interleukin-8,Inverse variance weighted,6,0.99 [0.89-1.1],0.781891556584978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL4,C-C motif chemokine 4,Inverse variance weighted,18,1.01 [0.97-1.05],0.782250795474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL18,Interleukin-18,Inverse variance weighted,16,0.99 [0.9-1.08],0.783474079340177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,0.99 [0.91-1.07],0.783767880803297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ELOA,Elongin-A,Inverse variance weighted,2,0.96 [0.72-1.29],0.787200209538439,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACY1,Aminoacylase-1,Inverse variance weighted,4,0.98 [0.88-1.1],0.788983898059741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,1.01 [0.95-1.07],0.789869200905389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAXX,Protein PAXX,Inverse variance weighted,3,0.99 [0.91-1.07],0.790217347697571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.99 [0.88-1.1],0.790864364880104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.99 [0.92-1.06],0.792412138211618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOL1,Apolipoprotein L1,Inverse variance weighted,3,1.01 [0.93-1.09],0.792941149944454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PKD2,Polycystin-2,Inverse variance weighted,3,0.96 [0.68-1.34],0.795117014259154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1 [0.96-1.03],0.795791785476651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,0.99 [0.95-1.04],0.796090706855045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1 [0.96-1.03],0.796979264983073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,0.99 [0.96-1.04],0.800018114721935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.03 [0.82-1.3],0.80090217504616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.99 [0.91-1.07],0.803624449033372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.99 [0.93-1.06],0.803825214295761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADA,Adenosine deaminase,Inverse variance weighted,22,1 [0.98-1.02],0.804668213810681,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.02 [0.9-1.14],0.807112809630652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLB,Beta-klotho,Inverse variance weighted,32,1 [0.98-1.02],0.809679854431885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.01 [0.91-1.13],0.809880427257896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,5,1.01 [0.92-1.11],0.809936292858407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.98 [0.84-1.14],0.810185412591475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.99 [0.91-1.08],0.811750617354981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Inverse variance weighted,8,0.99 [0.95-1.04],0.814394383269402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,23,1 [0.98-1.03],0.816268247104665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAYN,Layilin,Inverse variance weighted,20,1 [0.97-1.04],0.816402365112985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MDK,Midkine,Inverse variance weighted,4,1.01 [0.92-1.11],0.817826172353216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,26,1 [0.98-1.02],0.818515923060126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1 [0.97-1.04],0.82510129561372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,14,1 [0.96-1.03],0.825134246704697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,1 [0.97-1.03],0.825247557605367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPPK1,Epiplakin,Inverse variance weighted,33,1 [0.97-1.02],0.825448892385002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS4,Galectin-4,Inverse variance weighted,4,0.98 [0.86-1.13],0.825849433002053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.99 [0.92-1.07],0.825896438364234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NUDT16,U8 snoRNA-decapping enzyme,Inverse variance weighted,4,0.99 [0.94-1.05],0.831525965043576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,0.99 [0.93-1.06],0.832096098091231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1 [0.97-1.04],0.83273779109646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1 [0.97-1.04],0.835626680565619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,3,0.99 [0.93-1.06],0.838039535390854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,1 [0.96-1.05],0.838635746926003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL16,Pro-interleukin-16,Inverse variance weighted,16,1 [0.96-1.03],0.840500140747564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.01 [0.9-1.14],0.84227992327186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,1.01 [0.91-1.12],0.84293545603832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDLIM7,PDZ and LIM domain protein 7,Wald ratio,1,0.97 [0.7-1.34],0.843119261030145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,17,1 [0.97-1.03],0.847656511251169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.01 [0.95-1.07],0.848292261888731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FIS1,Mitochondrial fission 1 protein,Wald ratio,1,1.01 [0.93-1.09],0.848374871688311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.01 [0.9-1.14],0.850082604593005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HJV,Hemojuvelin,Wald ratio,1,1.01 [0.94-1.08],0.852476891408837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.99 [0.88-1.11],0.853031616952988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.98 [0.78-1.22],0.85447322464072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CSTB,Cystatin-B,Inverse variance weighted,28,1 [0.97-1.04],0.854890008501937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1 [0.96-1.05],0.85660148385829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.02 [0.79-1.32],0.857358388532898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1 [0.98-1.02],0.857508403601261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.98-1.02],0.858367486367237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.98-1.02],0.859071431700588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.01 [0.9-1.14],0.860632961291727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.98-1.02],0.860687476093463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DDT,D-dopachrome decarboxylase,Inverse variance weighted,2,0.99 [0.87-1.12],0.863084241475856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN4,CCN family member 4,Inverse variance weighted,27,1 [0.97-1.03],0.863694384833193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1 [0.95-1.06],0.864974738769082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OSM,Oncostatin-M,Wald ratio,1,1.02 [0.84-1.24],0.86669511672973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,18,1 [0.96-1.05],0.868848420442572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SRP14,Signal recognition particle 14 kDa protein,Wald ratio,1,0.98 [0.76-1.26],0.870315117319178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1 [0.95-1.04],0.871674201131894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALCA,Calcitonin,Inverse variance weighted,5,1.01 [0.88-1.16],0.871759810127969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1 [0.97-1.03],0.872224030667093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,1 [0.95-1.04],0.872894558576112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1 [0.95-1.06],0.873973574747603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.98 [0.76-1.27],0.873974519968221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SELP,P-selectin,Inverse variance weighted,8,1 [0.95-1.05],0.875485101559297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.99 [0.91-1.08],0.876640107852334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,1 [0.96-1.04],0.876964060721762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.01 [0.92-1.11],0.877187932471609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DTYMK,Thymidylate kinase,Inverse variance weighted,4,1.02 [0.83-1.25],0.878051812709998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPO,Erythropoietin,Inverse variance weighted,5,0.99 [0.82-1.19],0.878240292409594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DCXR,L-xylulose reductase,Inverse variance weighted,2,0.99 [0.92-1.08],0.87914900013662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRYBB2,Beta-crystallin B2,Wald ratio,1,1.02 [0.83-1.24],0.879482201299547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1 [0.96-1.04],0.879703022549336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNR,Tenascin-R,Inverse variance weighted,16,1 [0.97-1.03],0.879777196888132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.01 [0.91-1.11],0.883089222037582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFD,Complement factor D,Inverse variance weighted,11,1 [0.95-1.06],0.883529353944872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.02 [0.83-1.25],0.885203809887308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.98-1.02],0.887160066911722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COLEC12,Collectin-12,Inverse variance weighted,11,1 [0.95-1.05],0.889248018860443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APCS,Serum amyloid P-component,Inverse variance weighted,4,1 [0.95-1.06],0.889373601958401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD276,CD276 antigen,Inverse variance weighted,20,1 [0.97-1.02],0.902806697471588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,YES1,Tyrosine-protein kinase Yes,Inverse variance weighted,2,1.02 [0.72-1.45],0.902952130859354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1 [0.95-1.05],0.904851265731059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK6,Kallikrein-6,Inverse variance weighted,4,1 [0.94-1.07],0.905028839818968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LMNB2,Lamin-B2,Wald ratio,1,1.02 [0.73-1.42],0.90921028926723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1 [0.98-1.02],0.909756038314404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,F11R,Junctional adhesion molecule A,Wald ratio,1,0.99 [0.79-1.24],0.910838797619628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD7,T-cell antigen CD7,Inverse variance weighted,8,1 [0.97-1.03],0.913143828540948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1 [0.91-1.08],0.913908381127014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.01 [0.81-1.27],0.915760195553539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.01 [0.79-1.29],0.916038745727443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,1 [0.91-1.09],0.917224077534122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RBP2,Retinol-binding protein 2,Wald ratio,1,0.99 [0.79-1.24],0.917403187710862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1 [0.9-1.09],0.919184723232385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,1 [0.96-1.05],0.919673382733552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADH1B,All-trans-retinol dehydrogenase,Inverse variance weighted,3,1 [0.94-1.07],0.920125945110044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1 [0.97-1.03],0.920471846362537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1 [0.98-1.03],0.922301380470029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDIA4,Protein disulfide-isomerase A4,Wald ratio,1,0.99 [0.83-1.19],0.922894123315946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1 [0.97-1.03],0.924483223129225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1 [0.97-1.03],0.924569526609937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1 [0.9-1.1],0.927606839510068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.01 [0.81-1.25],0.929543524757363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,1 [0.91-1.09],0.931339897130629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,A1BG,Alpha-1B-glycoprotein,Inverse variance weighted,5,1 [0.95-1.05],0.933409668636687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEMIP2,Cell surface hyaluronidase,Inverse variance weighted,4,1 [0.91-1.09],0.933914116949847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1 [0.92-1.08],0.934075627457368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NFKBIE,NF-kappa-B inhibitor epsilon,Inverse variance weighted,2,1 [0.95-1.05],0.934469986399731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,19,1 [0.98-1.03],0.936327071343782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RSPO1,R-spondin-1,Inverse variance weighted,5,1 [0.93-1.07],0.937117381537271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.99 [0.77-1.27],0.937667606252223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.99 [0.86-1.15],0.93776126051688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1 [0.94-1.06],0.938702889721426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TPR,Nucleoprotein TPR,Wald ratio,1,0.99 [0.8-1.23],0.939282542558417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,0.99 [0.8-1.23],0.940918607093768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.97-1.03],0.94477457507348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1 [0.91-1.1],0.945063165484134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.99 [0.74-1.33],0.945255609359661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD160,CD160 antigen,Inverse variance weighted,11,1 [0.97-1.03],0.945476727485484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1 [0.95-1.04],0.947522155754624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,9,1 [0.94-1.06],0.948628324876527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,1.01 [0.82-1.24],0.949879384849852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSZ,Cathepsin Z,Inverse variance weighted,3,1 [0.94-1.06],0.950441559116952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1 [0.91-1.1],0.954001689479527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLIC5,Chloride intracellular channel protein 5,Inverse variance weighted,2,1.01 [0.76-1.33],0.954528652708139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL5,C-C motif chemokine 5,Inverse variance weighted,2,1 [0.91-1.09],0.955113868167659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1 [0.96-1.04],0.95672330930376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1 [0.94-1.07],0.957239461788734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1 [0.84-1.18],0.958579378206647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,1 [0.83-1.19],0.959340026397105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1 [0.95-1.05],0.959464586564492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFNA1,Ephrin-A1,Inverse variance weighted,11,1 [0.95-1.05],0.959730150492027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTGES2,Prostaglandin E synthase 2,Wald ratio,1,0.99 [0.79-1.25],0.961181555116463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCG3,Secretogranin-3,Inverse variance weighted,32,1 [0.97-1.03],0.962019808743257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1 [0.89-1.13],0.962707882402207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LPL,Lipoprotein lipase,Inverse variance weighted,14,1 [0.93-1.07],0.966319128137164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1 [0.97-1.03],0.967648535834675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1 [0.91-1.1],0.967857798459236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1 [0.86-1.16],0.967913799287702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1 [0.96-1.04],0.968506755561615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COCH,Cochlin,Inverse variance weighted,17,1 [0.98-1.02],0.968911977293373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1 [0.86-1.17],0.96954004551644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IQGAP2,Ras GTPase-activating-like protein IQGAP2,Inverse variance weighted,2,1 [0.91-1.09],0.971093063179505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,1 [0.96-1.05],0.97500078583121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1 [0.86-1.17],0.977128800560129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1 [0.97-1.03],0.980158077585801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1 [0.74-1.33],0.981278751359905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1 [0.93-1.08],0.981817584434975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HEXIM1,Protein HEXIM1,Wald ratio,1,1 [0.74-1.36],0.982678569260502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,4,1 [0.83-1.2],0.983622792787559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1 [0.9-1.11],0.983835184452526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1 [0.94-1.07],0.984437438981302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,9,1 [0.96-1.05],0.985133431920324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1 [0.93-1.07],0.985681726652035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STAT2,Signal transducer and activator of transcription 2,Inverse variance weighted,3,1 [0.94-1.06],0.986081917393732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C7,Complement component C7,Inverse variance weighted,38,1 [0.98-1.02],0.989366832797158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGRP,Agouti-related protein,Inverse variance weighted,3,1 [0.78-1.29],0.99002824693521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1 [0.98-1.02],0.991079305805785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,1 [0.83-1.21],0.991653870752839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1 [0.95-1.05],0.992863056452903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1 [0.96-1.04],0.993114647991162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1 [0.87-1.15],0.995613867814379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1 [0.98-1.02],0.9979917919886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1 [0.94-1.07],0.998933351329978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1 [0.97-1.03],0.998963630711748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,0.14 [0.1-0.2],3.22836239374649e-32,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNCA,Alpha-synuclein,Wald ratio,1,3.07 [2.27-4.16],3.74113728765918e-13,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,2.98 [2.22-4],3.7411372876592e-13,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,2.6 [1.85-3.65],3.69334137954131e-08,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRN,Progranulin,Inverse variance weighted,46,1.09 [1.06-1.13],3.71336997799023e-07,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.75 [0.66-0.85],5.88655742804136e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNAP25,Synaptosomal-associated protein 25,Inverse variance weighted,13,1.17 [1.09-1.25],1.61378438694255e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.64 [1.29-2.09],5.44676215141495e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS4,Galectin-4,Inverse variance weighted,15,0.93 [0.9-0.96],7.5075674352071e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1.13 [1.06-1.2],0.000105336150406955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.88 [0.82-0.94],0.000291250214585534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GSTA1,Glutathione S-transferase A1,Wald ratio,1,0.55 [0.4-0.77],0.000427288661827799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP7,Matrilysin,Wald ratio,1,0.8 [0.71-0.91],0.000545334215570995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.06 [1.02-1.09],0.000643480856268813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KITLG,Kit ligand,Inverse variance weighted,30,1.11 [1.04-1.18],0.0010414028027251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGA2,Integrin alpha-2,Inverse variance weighted,13,1.18 [1.07-1.3],0.00130623114414624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TDRKH,Tudor and KH domain-containing protein,Wald ratio,1,0.59 [0.42-0.82],0.00150011551372349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNAP29,Synaptosomal-associated protein 29,Wald ratio,1,0.61 [0.46-0.83],0.00150011551372349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FIS1,Mitochondrial fission 1 protein,Inverse variance weighted,3,0.77 [0.66-0.91],0.00150872306624212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,11,1.13 [1.05-1.21],0.00157289333592821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.89 [0.83-0.96],0.001575970265989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.26 [1.09-1.46],0.00160399960229201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.89 [1.27-2.82],0.00180303711693547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PKD2,Polycystin-2,Inverse variance weighted,3,0.73 [0.59-0.89],0.00238237164189899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN1,CCN family member 1,Inverse variance weighted,6,1.46 [1.14-1.87],0.0030325150945024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.34 [1.1-1.63],0.00353489726371586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.04 [1.01-1.07],0.00396637860169403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.9 [0.83-0.97],0.00563366852618038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.96 [0.94-0.99],0.00642252323996014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MPO,Myeloperoxidase,Inverse variance weighted,17,1.06 [1.02-1.1],0.00652718139967135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,0.83 [0.72-0.95],0.00683036552082019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSB,Cathepsin B,Inverse variance weighted,28,0.93 [0.88-0.98],0.00702004891675131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.75 [0.61-0.92],0.00705714001034647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KYNU,Kynureninase,Inverse variance weighted,3,1.45 [1.11-1.9],0.00719543787146955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.84 [0.75-0.96],0.00722531119027337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CST3,Cystatin-C,Inverse variance weighted,3,1.28 [1.06-1.54],0.00870421961939962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,1.07 [1.02-1.13],0.00913057950397697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.25 [1.06-1.48],0.00932155559970672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.04 [1.01-1.07],0.00989989556185502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.75 [0.6-0.93],0.0100488074121232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.96 [0.93-0.99],0.010240247017766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.92 [0.86-0.98],0.0103772204245882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.58 [0.38-0.88],0.0104493914800243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NRP2,Neuropilin-2,Inverse variance weighted,14,1.15 [1.03-1.29],0.0109137307414712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.29 [1.06-1.58],0.0113668272964418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MYH9,Myosin-9,Inverse variance weighted,3,0.82 [0.7-0.96],0.0125768167375477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.93 [0.87-0.98],0.0134803776741387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,4,0.81 [0.68-0.96],0.0139642106519271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",Wald ratio,1,1.32 [1.06-1.66],0.014616327744006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.32 [1.06-1.65],0.0147607579173456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.75 [0.6-0.95],0.0152529965651745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,F2R,Proteinase-activated receptor 1,Inverse variance weighted,6,1.14 [1.02-1.26],0.016465370572212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK10,Kallikrein-10,Wald ratio,1,0.65 [0.46-0.93],0.0178662617879703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPON1,Spondin-1,Inverse variance weighted,4,1.19 [1.03-1.38],0.0189854967973658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.09 [1.01-1.18],0.0197689746988205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,1.35 [1.05-1.75],0.0198628237208617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.96 [0.93-0.99],0.0210643033356661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.92 [0.85-0.99],0.0211190462377008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.16 [1.02-1.31],0.0224885314767282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RETN,Resistin,Inverse variance weighted,19,0.9 [0.83-0.99],0.0228978039542588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.11 [1.01-1.21],0.0250821457419292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK11,Kallikrein-11,Inverse variance weighted,13,1.09 [1.01-1.17],0.025288105881055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.35 [1.04-1.76],0.0255479756351791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.12 [1.01-1.23],0.0258540154534585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL6,Interleukin-6,Inverse variance weighted,6,0.93 [0.88-0.99],0.025892267386844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.45 [1.04-2.02],0.027347102329743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.09 [1.01-1.17],0.0281932472687873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.2 [1.02-1.41],0.0296964074522044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.02 [1-1.04],0.0299231050616585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.08 [1.01-1.16],0.0299546367602638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,21,1.08 [1.01-1.15],0.0299607510962466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.78 [0.62-0.98],0.0303859021521123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPE,Carboxypeptidase E,Inverse variance weighted,10,0.89 [0.81-0.99],0.0306544640889036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,Inverse variance weighted,29,1.03 [1-1.06],0.0320404358666576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.72 [0.53-0.97],0.0332359255330921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.12 [1.01-1.24],0.0343887405365004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLG,Plasminogen,Inverse variance weighted,6,1.23 [1.01-1.5],0.0355390723439267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.19 [1.01-1.4],0.0356722346077292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.56 [1.03-2.35],0.0357686965833415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOL1,Apolipoprotein L1,Inverse variance weighted,46,0.97 [0.95-1],0.0358176562734397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PSIP1,PC4 and SFRS1-interacting protein,Wald ratio,1,0.7 [0.5-0.98],0.0359208777324494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.96 [0.93-1],0.0367782492724672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.09 [1-1.18],0.0372968721865382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.11 [1.01-1.23],0.0383944517189266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,F7,Coagulation factor VII,Inverse variance weighted,10,1.09 [1-1.19],0.0391738039867651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.08 [1-1.15],0.03982935889801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LPL,Lipoprotein lipase,Inverse variance weighted,8,0.69 [0.48-0.99],0.0432611676150949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.1 [1-1.21],0.0434683558421098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.48 [1.01-2.17],0.0436299037840751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.84 [0.71-1],0.0439029707299037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.16 [1-1.34],0.0445266993380013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VWC2,Brorin,Inverse variance weighted,12,1.12 [1-1.26],0.0478347830670626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.93 [0.87-1],0.0485983925114957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.82 [0.67-1],0.0490421376092787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.9 [0.8-1],0.051149016347153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,5,1.13 [1-1.27],0.0518479537602755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.16 [1-1.35],0.0520886652280847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MFGE8,Lactadherin,Inverse variance weighted,15,1.18 [1-1.39],0.0528268430967561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.92 [0.84-1],0.0556501868349349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINH1,Serpin H1,Inverse variance weighted,5,0.9 [0.8-1],0.056663966439876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,1.08 [1-1.17],0.0576233011721937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPB2,Carboxypeptidase B2,Inverse variance weighted,4,1.32 [0.99-1.76],0.0605118620720075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINA4,Kallistatin,Inverse variance weighted,7,1.28 [0.99-1.64],0.0606183465696149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.02 [1-1.04],0.0611084386221004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.96 [0.92-1],0.0613569284325228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HHEX,Hematopoietically-expressed homeobox protein HHEX,Wald ratio,1,0.73 [0.52-1.02],0.0616674575355881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.87 [0.76-1.01],0.0629250008715477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN3,CCN family member 3,Inverse variance weighted,17,1.05 [1-1.1],0.0634080439040032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.85 [0.71-1.01],0.0635630090617937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,9,0.81 [0.65-1.01],0.0640899607551858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CETN2,Centrin-2,Wald ratio,1,0.76 [0.58-1.02],0.0651498966796537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.28 [0.98-1.66],0.0668582009516604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.82 [0.67-1.01],0.0673740652477571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DDT,D-dopachrome decarboxylase,Wald ratio,1,1.34 [0.98-1.85],0.0706075464170794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.06 [1-1.13],0.0706631659081076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.14 [0.99-1.32],0.0709752879824844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.11 [0.99-1.25],0.0725207428619995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.21 [0.98-1.48],0.0725812809580307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFH,Complement factor H,Inverse variance weighted,7,0.93 [0.86-1.01],0.072945982762061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.84 [0.69-1.02],0.0749989784255257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADH1B,All-trans-retinol dehydrogenase,Wald ratio,1,0.84 [0.7-1.02],0.0758535728831237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.04 [1-1.09],0.0765171933509501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.16 [0.98-1.36],0.0786949620944511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MATN2,Matrilin-2,Inverse variance weighted,28,1.03 [1-1.06],0.0795365004773345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.05 [0.99-1.1],0.0795813953230321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.16 [0.98-1.37],0.0819437876466236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.94 [0.88-1.01],0.0831345159633503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HEPACAM2,HEPACAM family member 2,Inverse variance weighted,69,0.98 [0.96-1],0.0832368346098917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRSS2,Trypsin-2,Inverse variance weighted,17,0.93 [0.85-1.01],0.0839520739851095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOD,Apolipoprotein D,Inverse variance weighted,9,0.72 [0.49-1.05],0.0840253750862007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.05 [0.99-1.12],0.0840778031339488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.96 [0.93-1.01],0.0859696134210446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLB,Beta-klotho,Inverse variance weighted,23,1.06 [0.99-1.12],0.086230731432428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.04 [0.99-1.1],0.0865198355773171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.04 [0.99-1.08],0.0869579205296346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,Inverse variance weighted,4,0.87 [0.74-1.02],0.0876385369924084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,POMC,Pro-opiomelanocortin,Inverse variance weighted,15,0.94 [0.88-1.01],0.0886989612087492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.94 [0.88-1.01],0.0890461159558746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MSLN,Mesothelin,Inverse variance weighted,11,1.09 [0.99-1.21],0.0890645786155801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SELE,E-selectin,Inverse variance weighted,20,0.94 [0.87-1.01],0.0898339310933831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.21 [0.97-1.51],0.0910579929456007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.89 [0.78-1.02],0.0927387085551309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LMNB2,Lamin-B2,Inverse variance weighted,8,1.1 [0.98-1.23],0.0932407185565309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAT,Linker for activation of T-cells family member 1,Inverse variance weighted,2,0.83 [0.67-1.03],0.0951969118491498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.8 [0.62-1.04],0.0969350292366973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.1 [0.98-1.23],0.0973943330396867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.04 [0.99-1.1],0.100131076913451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.94 [0.86-1.01],0.101435036901184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,1.18 [0.97-1.43],0.102129313931077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.09 [0.98-1.21],0.104108528677386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.86 [0.72-1.03],0.105508833782714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,3,1.14 [0.97-1.34],0.105518871275874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGR3,Anterior gradient protein 3,Inverse variance weighted,5,1.21 [0.96-1.51],0.105743130141248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.9 [0.79-1.02],0.10672160935424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FUS,RNA-binding protein FUS,Wald ratio,1,1.27 [0.95-1.7],0.108535718670942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.09 [0.98-1.22],0.109732752384479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,0.93 [0.85-1.02],0.110210213257479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OPLAH,5-oxoprolinase,Inverse variance weighted,3,0.86 [0.71-1.04],0.11025204037067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CNTN3,Contactin-3,Inverse variance weighted,20,0.92 [0.83-1.02],0.111299510509481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EZR,Ezrin,Wald ratio,1,0.8 [0.6-1.06],0.11484293649934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.97 [0.93-1.01],0.116448749597354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.22 [0.95-1.57],0.117036051962036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HTRA2,"Serine protease HTRA2, mitochondrial",Wald ratio,1,1.26 [0.94-1.68],0.117446052588297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.05 [0.99-1.12],0.118465294617105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NGRN,Neugrin,Inverse variance weighted,4,1.1 [0.98-1.25],0.11897299877397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.29 [0.94-1.76],0.119586850875337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCAMP3,Secretory carrier-associated membrane protein 3,Wald ratio,1,0.83 [0.66-1.05],0.120750712164161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.73 [0.49-1.09],0.121528813563076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.93 [0.85-1.02],0.122366242702246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PPL,Periplakin,Inverse variance weighted,2,1.31 [0.93-1.85],0.123103739379696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGRP,Agouti-related protein,Inverse variance weighted,16,1.1 [0.97-1.25],0.125404920211382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.98 [0.94-1.01],0.125458139863859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL22,Interleukin-22,Inverse variance weighted,4,0.72 [0.47-1.1],0.125813392825873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFHR2,Complement factor H-related protein 2,Inverse variance weighted,22,0.96 [0.92-1.01],0.125999885267706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.97 [0.93-1.01],0.126808332779676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.1 [0.97-1.25],0.127481548077006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK14,Kallikrein-14,Inverse variance weighted,15,1.08 [0.98-1.2],0.128188484201382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDLIM7,PDZ and LIM domain protein 7,Wald ratio,1,1.32 [0.92-1.88],0.12947556614145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.02 [0.99-1.05],0.133264820841794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BSG,Basigin,Inverse variance weighted,6,1.1 [0.97-1.26],0.134432692673484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.86 [0.71-1.05],0.135571770061299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.36 [0.91-2.04],0.135953528145931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.08 [0.97-1.21],0.135984254779582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.92 [0.83-1.03],0.136725027759619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.05 [0.98-1.13],0.136743034134266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,6,1.21 [0.94-1.55],0.138396083693734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.07 [0.98-1.17],0.139207314019981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.67 [0.4-1.14],0.139238964933251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.09 [0.97-1.21],0.139635041592493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.98 [0.94-1.01],0.139943028350419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.9 [0.79-1.03],0.140311351436387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.85 [0.69-1.05],0.140449492895264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.95 [0.89-1.02],0.141008637431305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PGA4,Pepsin A-4,Inverse variance weighted,7,0.92 [0.83-1.03],0.142181007000297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.1 [0.97-1.26],0.142904081056768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MENT,Protein MENT,Inverse variance weighted,28,1.06 [0.98-1.16],0.144406757817757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.96-1.01],0.144935712794674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.1 [0.97-1.25],0.145178162445865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PENK,Proenkephalin-A,Inverse variance weighted,15,1.06 [0.98-1.14],0.146713496888261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.05 [0.98-1.13],0.147794866391317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.07 [0.98-1.17],0.149701620524304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.93 [0.84-1.03],0.152742379818148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.95 [0.88-1.02],0.152781849589191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.19 [0.94-1.51],0.153666962505987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C5,Complement C5,Inverse variance weighted,3,1.06 [0.98-1.16],0.15370549662605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APLP1,Amyloid-like protein 1,Inverse variance weighted,9,1.05 [0.98-1.11],0.156450228910022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,0.82 [0.63-1.08],0.159544161014195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.07 [0.97-1.17],0.160989282365377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KCTD5,BTB/POZ domain-containing protein KCTD5,Inverse variance weighted,5,0.9 [0.77-1.05],0.163336298036986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TP53I3,Quinone oxidoreductase PIG3,Inverse variance weighted,4,0.94 [0.86-1.03],0.163464622249836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.99-1.07],0.16361928336543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.91 [0.8-1.04],0.163835749639914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NFASC,Neurofascin,Inverse variance weighted,6,0.79 [0.57-1.1],0.165948392603492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,0.91 [0.81-1.04],0.165974203588566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FBLN2,Fibulin-2,Inverse variance weighted,6,1.14 [0.95-1.38],0.168742605688027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FURIN,Furin,Inverse variance weighted,3,0.89 [0.76-1.05],0.171479193654019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.08 [0.97-1.19],0.171959838284865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC1B,C-type lectin domain family 1 member B,Wald ratio,1,1.21 [0.92-1.6],0.172803710951397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.91 [0.79-1.04],0.173148020083959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.81 [0.6-1.1],0.173591520118441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.97 [0.92-1.01],0.174212728001936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LMNB1,Lamin-B1,Inverse variance weighted,3,1.09 [0.96-1.23],0.174485672339439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.08 [0.96-1.22],0.181434302390691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSL,Cathepsin L1,Inverse variance weighted,29,1.04 [0.98-1.1],0.183442580669669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.03 [0.99-1.08],0.183680850543545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,1.16 [0.93-1.45],0.188080567565807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.95 [0.87-1.03],0.18946038274807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK8,Kallikrein-8,Inverse variance weighted,5,0.89 [0.75-1.06],0.191044507763309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.13 [0.94-1.36],0.191383168582806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.17 [0.92-1.48],0.192127571698814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.05 [0.97-1.13],0.192794978214237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP3,Stromelysin-1,Inverse variance weighted,4,1.13 [0.94-1.35],0.19445229956168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.2 [0.91-1.57],0.194889234020575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.14 [0.94-1.38],0.197350529153023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.95 [0.87-1.03],0.197769409057704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FETUB,Fetuin-B,Inverse variance weighted,5,1.17 [0.92-1.49],0.198610436053906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PROK1,Prokineticin-1,Inverse variance weighted,4,0.86 [0.69-1.08],0.19929297327803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.1 [0.95-1.26],0.199903689546771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,0.95 [0.88-1.03],0.200669375758821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAYN,Layilin,Inverse variance weighted,3,1.13 [0.94-1.36],0.201298298537111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MPI,Mannose-6-phosphate isomerase,Inverse variance weighted,3,1.07 [0.97-1.18],0.203428324148499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Wald ratio,1,1.14 [0.93-1.39],0.203961123562012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.11 [0.95-1.29],0.204118792395997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.98 [0.94-1.01],0.204203275635242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CES1,Liver carboxylesterase 1,Inverse variance weighted,19,0.93 [0.83-1.04],0.205369686090441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.88 [0.71-1.08],0.206675542119053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.94 [0.84-1.04],0.207630709743487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1.23 [0.89-1.7],0.207723508063388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.96 [0.9-1.02],0.208341020629141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.93 [0.83-1.04],0.211453482066115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.93 [0.83-1.04],0.211461949998859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.09 [0.95-1.26],0.215459927820224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CST7,Cystatin-F,Inverse variance weighted,46,0.98 [0.95-1.01],0.216975040094047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,2,1.15 [0.92-1.45],0.217287611791504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SORT1,Sortilin,Inverse variance weighted,11,1.14 [0.92-1.42],0.219278879876662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [0.97-1.14],0.220322527233603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.27 [0.86-1.88],0.222636076313487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP1,Interstitial collagenase,Inverse variance weighted,14,0.96 [0.9-1.02],0.222781349018208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,0.88 [0.72-1.08],0.225035043955471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.07 [0.96-1.19],0.225341772863004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.97 [0.92-1.02],0.225782475960099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,1.19 [0.9-1.59],0.22793084962312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,22,1.03 [0.98-1.09],0.228127096157466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,0.8 [0.56-1.15],0.232912916360378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STAB2,Stabilin-2,Inverse variance weighted,14,1.06 [0.96-1.17],0.234436991696454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",Inverse variance weighted,4,1.1 [0.94-1.29],0.235958084016504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STX8,Syntaxin-8,Wald ratio,1,1.1 [0.94-1.28],0.241103864230637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PPP1R2,Protein phosphatase inhibitor 2,Wald ratio,1,0.84 [0.62-1.13],0.242413763661113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGLN1,Egl nine homolog 1,Wald ratio,1,0.83 [0.6-1.14],0.242780404376732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.97 [0.92-1.02],0.243489003025522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,QDPR,Dihydropteridine reductase,Wald ratio,1,1.54 [0.74-3.17],0.245315626894528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.89 [0.72-1.09],0.246051210599439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.93 [0.83-1.05],0.246455100781004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GAST,Gastrin,Inverse variance weighted,9,0.95 [0.86-1.04],0.249204942429072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC3B,Tetranectin,Inverse variance weighted,2,1.25 [0.86-1.82],0.24939484858065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STC2,Stanniocalcin-2,Inverse variance weighted,10,1.09 [0.94-1.27],0.250405526578391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.04 [0.98-1.1],0.250851634934269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD27,CD27 antigen,Inverse variance weighted,9,0.9 [0.75-1.08],0.252535768636789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.08 [0.95-1.22],0.25372529063436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,4,1.07 [0.96-1.19],0.253740942333701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.18 [0.89-1.57],0.255301029579498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,4,0.91 [0.78-1.07],0.255439267841121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.81 [0.55-1.17],0.255820820452196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD83,CD83 antigen,Inverse variance weighted,14,0.94 [0.84-1.05],0.256283476133241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.97 [0.91-1.03],0.256347395732429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFI,Complement factor I,Wald ratio,1,0.79 [0.52-1.19],0.258398771184142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.1 [0.93-1.28],0.261037093412437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BRK1,Protein BRICK1,Inverse variance weighted,10,1.13 [0.91-1.39],0.262238190427389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,Inverse variance weighted,4,1.17 [0.89-1.53],0.262936544160693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HEPH,Hephaestin,Inverse variance weighted,6,0.95 [0.86-1.04],0.262981561182933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.1 [0.93-1.3],0.26336912595023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NID1,Nidogen-1,Inverse variance weighted,6,1.05 [0.96-1.15],0.264212567693785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COX6B1,Cytochrome c oxidase subunit 6B1,Wald ratio,1,1.18 [0.88-1.57],0.26518419980797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.81 [0.56-1.18],0.27063733465228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.02 [0.99-1.05],0.272711265369606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.04 [0.97-1.12],0.2734775494343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.05 [0.96-1.15],0.273918753133688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNM3,Dynamin-3,Inverse variance weighted,11,0.96 [0.9-1.03],0.275354814266009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.15 [0.9-1.47],0.275539206149505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,0.93 [0.82-1.06],0.277219163012463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCG3,Secretogranin-3,Inverse variance weighted,16,1.04 [0.97-1.12],0.277393081770707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,0.92 [0.79-1.07],0.279334716839641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDKN1A,Cyclin-dependent kinase inhibitor 1,Inverse variance weighted,2,0.89 [0.72-1.1],0.279750059276844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,Wald ratio,1,1.09 [0.93-1.29],0.279831191173516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.1 [0.93-1.31],0.280259099338757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.94 [0.85-1.05],0.280531272944263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.04 [0.97-1.11],0.281234503578863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NIT2,Omega-amidase NIT2,Inverse variance weighted,2,0.81 [0.54-1.19],0.282771019390324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.32 [0.79-2.19],0.284151864748459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGRN,Agrin,Inverse variance weighted,14,1.05 [0.96-1.14],0.285076737226987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.96 [0.89-1.03],0.285394049829669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1.01 [0.99-1.03],0.287213460498738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS3,Galectin-3,Inverse variance weighted,15,1.06 [0.95-1.17],0.288312530807177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SDC4,Syndecan-4,Inverse variance weighted,35,0.97 [0.93-1.02],0.288602472303102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.06 [0.95-1.17],0.289069114669503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAMP2,Lysosome-associated membrane glycoprotein 2,Inverse variance weighted,6,0.9 [0.73-1.1],0.289464190573708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,1.06 [0.95-1.18],0.290270339717838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.2 [0.85-1.7],0.290749554872602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,1.2 [0.86-1.67],0.291877816565041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Wald ratio,1,0.66 [0.31-1.43],0.292079321812228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.93 [0.81-1.07],0.292518134575498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.97 [0.93-1.02],0.292739471479355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AREG,Amphiregulin,Inverse variance weighted,5,1.07 [0.94-1.21],0.292746592494345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,Inverse variance weighted,4,0.93 [0.81-1.07],0.292953052537538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.15 [0.88-1.5],0.293783093881292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRELP,Prolargin,Inverse variance weighted,5,0.91 [0.76-1.09],0.294653998247493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.08 [0.93-1.25],0.295661258193372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OMD,Osteomodulin,Inverse variance weighted,15,1.03 [0.98-1.09],0.295987023864826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,0.96 [0.89-1.04],0.297207632774475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.95 [0.85-1.05],0.299879269640271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLIN1,Perilipin-1,Wald ratio,1,0.86 [0.65-1.14],0.301483746594523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCHE,Cholinesterase,Inverse variance weighted,38,1.02 [0.98-1.06],0.302514590698042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.08 [0.93-1.26],0.303337730951059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,L1CAM,Neural cell adhesion molecule L1,Inverse variance weighted,21,1.05 [0.96-1.15],0.305998652392406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN2,CCN family member 2,Inverse variance weighted,15,1.1 [0.91-1.34],0.306157080125561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRP,Gastrin-releasing peptide,Inverse variance weighted,21,1.02 [0.98-1.07],0.306535907469363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.85 [0.62-1.16],0.306860869578522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C7,Complement component C7,Inverse variance weighted,26,1.01 [0.99-1.04],0.307642567444364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.07 [0.94-1.21],0.307678799867016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.08 [0.93-1.27],0.307909756867392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.95 [0.86-1.05],0.309881425103503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.9 [0.74-1.1],0.311357314956508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.87 [0.67-1.14],0.311698135354473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MME,Neprilysin,Inverse variance weighted,46,1.02 [0.99-1.05],0.31177988567141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.97 [0.91-1.03],0.31259728090204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPXM1,Probable carboxypeptidase X1,Inverse variance weighted,9,0.91 [0.75-1.1],0.313697942733394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.07 [0.94-1.23],0.315459891992112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTSL5,ADAMTS-like protein 5,Inverse variance weighted,3,1.06 [0.95-1.17],0.317703538432742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.95 [0.86-1.05],0.318237714990352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COCH,Cochlin,Inverse variance weighted,21,1.04 [0.96-1.13],0.320228607986922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANG,Angiogenin,Inverse variance weighted,8,1.09 [0.92-1.3],0.320571138098348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.08 [0.93-1.26],0.32443083334346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRND,Prion-like protein doppel,Inverse variance weighted,15,1.04 [0.97-1.11],0.32682043334009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD209,CD209 antigen,Inverse variance weighted,34,0.98 [0.95-1.02],0.328652308715008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,Inverse variance weighted,17,0.95 [0.87-1.05],0.328982515138691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.02 [0.98-1.08],0.329245681622736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.18 [0.84-1.67],0.331133989988233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLGN,Calmegin,Inverse variance weighted,6,0.96 [0.89-1.04],0.332105254692266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSD,Cathepsin D,Inverse variance weighted,7,1.07 [0.94-1.22],0.332583252070398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.9 [0.72-1.12],0.333578785007916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.92 [0.78-1.09],0.335967002240736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,37,1.03 [0.97-1.09],0.336561551327231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.07 [0.94-1.21],0.336588433968541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.19 [0.83-1.71],0.340248439878241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",Wald ratio,1,0.86 [0.62-1.18],0.341597316912551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CREG1,Protein CREG1,Inverse variance weighted,20,0.98 [0.93-1.03],0.343011936234557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRYBB2,Beta-crystallin B2,Inverse variance weighted,30,1.02 [0.98-1.06],0.343786372192479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.04 [0.96-1.13],0.344054129471819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.99-1.04],0.345838479525005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NRP1,Neuropilin-1,Inverse variance weighted,14,0.94 [0.83-1.07],0.346143554312887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DGKA,Diacylglycerol kinase alpha,Wald ratio,1,0.86 [0.63-1.18],0.347368369865286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.06 [0.94-1.2],0.347523829088131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,0.93 [0.81-1.08],0.348625230719243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.12 [0.88-1.44],0.350120980799099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.01 [0.99-1.04],0.351753131592649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Wald ratio,1,1.26 [0.77-2.05],0.351753652056065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPP1,Osteopontin,Inverse variance weighted,13,0.95 [0.84-1.06],0.35210125268315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD248,Endosialin,Inverse variance weighted,17,1.05 [0.95-1.17],0.354709808141169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.02 [0.97-1.08],0.356342064154979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TIMP3,Metalloproteinase inhibitor 3,Inverse variance weighted,6,0.94 [0.83-1.07],0.35883355534744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.85 [0.6-1.21],0.358937720735498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.99 [0.97-1.01],0.360600564076243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1.02 [0.98-1.05],0.361715091893676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RSPO1,R-spondin-1,Inverse variance weighted,8,1.04 [0.96-1.12],0.362208719447844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDHR2,Cadherin-related family member 2,Inverse variance weighted,13,1.06 [0.93-1.2],0.362295617677299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPO,Erythropoietin,Inverse variance weighted,11,0.97 [0.9-1.04],0.362669984984906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNN,Tenascin-N,Inverse variance weighted,41,1.01 [0.99-1.04],0.366786907618795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,21,1.04 [0.95-1.14],0.366799287412286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.03 [0.97-1.09],0.367251179135724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.97 [0.92-1.03],0.369295783486339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINB8,Serpin B8,Inverse variance weighted,29,0.99 [0.98-1.01],0.369688577485271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.76 [0.41-1.4],0.372958164298659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.16 [0.84-1.6],0.373081047974264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSO,Cathepsin O,Inverse variance weighted,19,0.93 [0.8-1.09],0.373372978158022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD160,CD160 antigen,Inverse variance weighted,24,1.02 [0.97-1.08],0.375314951140636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.23 [0.78-1.93],0.375708343678177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD48,CD48 antigen,Inverse variance weighted,14,0.94 [0.82-1.08],0.376912142763258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.03 [0.97-1.09],0.380445878651497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,22,1.01 [0.98-1.05],0.380596649395049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.16 [0.83-1.62],0.381898364978486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.04 [0.96-1.12],0.382913752212722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL11,Eotaxin,Inverse variance weighted,11,1.02 [0.97-1.07],0.385617776138168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ELN,Elastin,Inverse variance weighted,10,1.12 [0.87-1.44],0.385628813669629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.87 [0.64-1.19],0.386098452360847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.95 [0.85-1.07],0.386273279247615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AMBP,Protein AMBP,Inverse variance weighted,5,1.1 [0.89-1.37],0.387500040497193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.04 [0.95-1.13],0.390973266825645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL5,C-C motif chemokine 5,Inverse variance weighted,8,1.11 [0.88-1.4],0.391046790222391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFC1,Cryptic protein,Inverse variance weighted,11,0.95 [0.85-1.07],0.391059686289278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFD,Complement factor D,Wald ratio,1,0.88 [0.66-1.17],0.391447295678196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL19,Interleukin-19,Inverse variance weighted,10,1.03 [0.96-1.1],0.392004834453359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.86 [0.61-1.22],0.395664005371044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.93 [0.8-1.09],0.395833022667023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NT5E,5'-nucleotidase,Inverse variance weighted,45,1.01 [0.98-1.05],0.396346996756686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NFKBIE,NF-kappa-B inhibitor epsilon,Wald ratio,1,0.91 [0.72-1.14],0.398477369511596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.99 [0.97-1.01],0.399106562991818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.11 [0.87-1.4],0.400672413498586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.95 [0.85-1.07],0.400712781404656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.01 [0.98-1.04],0.401349584082509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.2 [0.79-1.83],0.401801851407675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1.05 [0.93-1.19],0.402145952651161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.92 [0.76-1.11],0.402597831998473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK6,Kallikrein-6,Inverse variance weighted,2,1.08 [0.9-1.3],0.404719320031596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DPT,Dermatopontin,Inverse variance weighted,4,1.08 [0.91-1.28],0.406205088462766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KHK,Ketohexokinase,Inverse variance weighted,4,0.92 [0.75-1.12],0.407512813172286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,0.96 [0.88-1.05],0.410140548258662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,1.06 [0.92-1.24],0.41102120686404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.15 [0.83-1.6],0.411203637713715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.07 [0.91-1.27],0.412246572273681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.95 [0.84-1.07],0.413533327329478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL4,C-C motif chemokine 4,Inverse variance weighted,37,1.01 [0.98-1.04],0.413600715168048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,0.88 [0.65-1.19],0.413860917775807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,0.93 [0.79-1.1],0.415566877806006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.97 [0.91-1.04],0.416519359729396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.87-1.06],0.417035125267416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSF,Cathepsin F,Inverse variance weighted,27,1.03 [0.96-1.1],0.419780379477154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALB1,Calbindin,Inverse variance weighted,9,0.97 [0.89-1.05],0.420276632554452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.96 [0.87-1.06],0.42145126717543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FLT3,Receptor-type tyrosine-protein kinase FLT3,Inverse variance weighted,8,0.94 [0.81-1.09],0.423401181290203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.93 [0.78-1.11],0.425839712486892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.96 [0.88-1.06],0.429739609672688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.1 [0.87-1.37],0.429875187072298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.14 [0.82-1.6],0.430265452549938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.96 [0.87-1.06],0.43307558084484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.96 [0.87-1.06],0.434401197362981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.08 [0.9-1.29],0.434555795388682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.95 [0.85-1.07],0.43499488278224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PCDH7,Protocadherin-7,Inverse variance weighted,3,0.61 [0.17-2.13],0.43576192510392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,33,1.02 [0.98-1.06],0.436014190159273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,1.03 [0.95-1.12],0.437702402532534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.03 [0.95-1.12],0.439786319462973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.03 [0.96-1.1],0.441699237019457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TCOF1,Treacle protein,Wald ratio,1,1.13 [0.82-1.56],0.442182597670059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.98 [0.92-1.04],0.442495337014931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,18,0.97 [0.9-1.05],0.442642913575114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.97 [0.89-1.05],0.443534762296563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCAN,Brevican core protein,Inverse variance weighted,12,1.03 [0.95-1.12],0.443765339781547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.97 [0.88-1.06],0.444017845568606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.17 [0.78-1.74],0.444551379246194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCL2,Apoptosis regulator Bcl-2,Inverse variance weighted,5,0.73 [0.32-1.65],0.444804591718224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ZNRD2,Protein ZNRD2,Inverse variance weighted,10,1.04 [0.95-1.13],0.445140357880267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,0.99 [0.95-1.02],0.4471697989251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.04 [0.94-1.14],0.447219695105777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALCA,Calcitonin,Inverse variance weighted,13,1.04 [0.95-1.13],0.447461233317933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SELP,P-selectin,Inverse variance weighted,4,1.08 [0.89-1.3],0.44765236424351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLK4,Kallikrein-4,Inverse variance weighted,5,0.9 [0.69-1.18],0.447752364835838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAXX,Protein PAXX,Wald ratio,1,1.06 [0.91-1.24],0.448180941916231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.97 [0.9-1.05],0.44841568211302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,1.13 [0.82-1.55],0.449985345487745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1.04 [0.95-1.13],0.450149241213949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.02 [0.97-1.07],0.450542212680685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.96 [0.86-1.07],0.45151178035623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.03 [0.96-1.09],0.451674212391909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.02 [0.96-1.09],0.452687641877924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.92 [0.75-1.14],0.456215891735568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.89 [0.65-1.21],0.459875548661884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTH,Parathyroid hormone,Inverse variance weighted,11,1.06 [0.91-1.23],0.460473792113471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.95 [0.82-1.09],0.46093976947315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTGES2,Prostaglandin E synthase 2,Inverse variance weighted,2,1.22 [0.72-2.06],0.462614628513628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.05 [0.92-1.21],0.463587718747562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.96 [0.86-1.07],0.465359423535595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN5,CCN family member 5,Inverse variance weighted,12,1.02 [0.97-1.07],0.466347593031187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.98 [0.93-1.03],0.469826739396746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.94 [0.78-1.12],0.47018624910376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,S100A11,Protein S100-A11,Wald ratio,1,0.91 [0.7-1.18],0.471604197437727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD99,CD99 antigen,Inverse variance weighted,4,0.9 [0.68-1.19],0.473172662670794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.06 [0.9-1.25],0.474229103418694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.99 [0.98-1.01],0.479619370977736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,1.08 [0.87-1.33],0.479702704385729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP10,Stromelysin-2,Wald ratio,1,0.88 [0.63-1.25],0.479826974519459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.98 [0.94-1.03],0.481082714128595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPON2,Spondin-2,Inverse variance weighted,3,0.94 [0.78-1.13],0.484879202161171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.06 [0.89-1.27],0.486705385240853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,16,0.98 [0.92-1.04],0.488025359722155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.04 [0.93-1.18],0.489090986080823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.93 [0.75-1.15],0.490025712842723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.98 [0.92-1.04],0.492105076994996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.91 [0.7-1.19],0.492639304148381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,0.94 [0.79-1.12],0.493498572453807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.96 [0.86-1.08],0.49406636997269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPA1,Carboxypeptidase A1,Inverse variance weighted,26,0.98 [0.92-1.04],0.495544646781126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.98 [0.93-1.03],0.497281603312449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GUCA2A,Guanylin,Inverse variance weighted,7,0.96 [0.86-1.07],0.498015334336002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MB,Myoglobin,Inverse variance weighted,9,0.96 [0.86-1.08],0.500561648095111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,0.89 [0.64-1.24],0.501362744236227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.22 [0.68-2.17],0.501906041920813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1.01 [0.98-1.05],0.502498402408346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DBI,Acyl-CoA-binding protein,Wald ratio,1,1.06 [0.89-1.28],0.508315620710587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DAG1,Dystroglycan,Wald ratio,1,1.12 [0.8-1.55],0.50964978695087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.95 [0.82-1.1],0.512814708904781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.04 [0.93-1.16],0.514983352291234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.08 [0.86-1.37],0.51503946291706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.95 [0.82-1.1],0.51566920194175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.91 [0.67-1.22],0.515914803600987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.94 [0.79-1.13],0.519053810205177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDH3,Cadherin-3,Inverse variance weighted,10,1.04 [0.93-1.16],0.519373450240457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.02 [0.96-1.08],0.519746222526444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.05 [0.9-1.23],0.520770840950266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSS,Cathepsin S,Inverse variance weighted,7,0.96 [0.86-1.08],0.520985698873806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.92 [0.7-1.2],0.521143637543628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.05 [0.91-1.2],0.521405598622924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,0.99 [0.96-1.02],0.522896032225843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LPA,Apolipoprotein(a),Inverse variance weighted,2,0.95 [0.82-1.11],0.523310449230565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,10,1.04 [0.93-1.16],0.523620479529092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.04 [0.92-1.17],0.524467882152501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.99 [0.96-1.02],0.524646199926616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BAG4,BAG family molecular chaperone regulator 4,Inverse variance weighted,2,0.87 [0.57-1.34],0.526430481979892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.94 [0.77-1.14],0.526479033416313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.02 [0.95-1.1],0.526871856141945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.97 [0.88-1.07],0.527972451869111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHMP6,Charged multivesicular body protein 6,Wald ratio,1,0.98 [0.9-1.05],0.528681131059712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHGB,Secretogranin-1,Inverse variance weighted,7,1.03 [0.95-1.11],0.530540082578465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.08 [0.85-1.38],0.53158906587352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.99 [0.95-1.02],0.533055579021938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,0.99 [0.96-1.02],0.534987426630258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,1.11 [0.8-1.55],0.535058075718068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.06 [0.88-1.26],0.537140052327405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C3,Complement C3,Inverse variance weighted,2,1.04 [0.91-1.19],0.537384381655433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PEBP1,Phosphatidylethanolamine-binding protein 1,Inverse variance weighted,2,0.92 [0.72-1.19],0.540210460039085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,5,1.08 [0.85-1.37],0.542080973309288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.22 [0.64-2.34],0.545236002132853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.01 [0.98-1.04],0.549113206969141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLF4,Krueppel-like factor 4,Wald ratio,1,1.15 [0.72-1.84],0.550949061918078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.01 [0.97-1.05],0.551131908357467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,1.03 [0.94-1.12],0.552637123374559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPI,Glucose-6-phosphate isomerase,Wald ratio,1,1.1 [0.8-1.53],0.553018432874849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.02 [0.96-1.09],0.553707110048874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD276,CD276 antigen,Inverse variance weighted,24,0.98 [0.93-1.04],0.555011898505082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS8,Galectin-8,Inverse variance weighted,8,0.95 [0.81-1.12],0.55507855256375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IFNLR1,Interferon lambda receptor 1,Wald ratio,1,0.93 [0.73-1.19],0.557412542791755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.04 [0.92-1.18],0.558818626430316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,18,1.01 [0.98-1.04],0.559023872793304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.98 [0.9-1.06],0.559268300457842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.03 [0.94-1.12],0.563556483591097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.02 [0.96-1.09],0.564975850162626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CPB1,Carboxypeptidase B,Inverse variance weighted,18,1.02 [0.96-1.08],0.566098270232402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.97 [0.88-1.07],0.567120878154801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGFLAM,Pikachurin,Wald ratio,1,1.14 [0.73-1.76],0.567213263537609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCN4,CCN family member 4,Inverse variance weighted,29,1.01 [0.97-1.05],0.568494944291471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.99 [0.95-1.03],0.569844087131761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,WNT9A,Protein Wnt-9a,Wald ratio,1,1.12 [0.76-1.64],0.571057802357393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.05 [0.88-1.26],0.571635526426649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TOP2B,DNA topoisomerase 2-beta,Wald ratio,1,0.9 [0.64-1.28],0.575047204868516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL17C,Interleukin-17C,Inverse variance weighted,5,0.95 [0.79-1.14],0.578319151636647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,59,1.01 [0.98-1.03],0.58144663120916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PSAP,Prosaposin,Inverse variance weighted,13,0.98 [0.93-1.04],0.581845802718562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACY1,Aminoacylase-1,Inverse variance weighted,6,1.03 [0.94-1.12],0.584422119982612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.01 [0.98-1.04],0.588165013231188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.05 [0.88-1.26],0.588874913446108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SDC1,Syndecan-1,Inverse variance weighted,12,1.02 [0.94-1.11],0.589329895508435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.95 [0.8-1.14],0.58960857294282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,1.04 [0.89-1.22],0.589940495364505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRSS8,Prostasin,Inverse variance weighted,14,0.97 [0.89-1.07],0.591162635834835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,19,1.01 [0.97-1.05],0.591901103319789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LCN15,Lipocalin-15,Inverse variance weighted,22,0.99 [0.97-1.02],0.592485625457353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,0.96 [0.82-1.12],0.594807669645754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,Inverse variance weighted,3,1.03 [0.92-1.15],0.595841310610879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.06 [0.86-1.3],0.596706297038972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ICAM4,Intercellular adhesion molecule 4,Inverse variance weighted,58,1.01 [0.98-1.03],0.598145630594644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,0.95 [0.77-1.16],0.600930445191485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.06 [0.85-1.33],0.602373898273082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,S100P,Protein S100-P,Inverse variance weighted,4,1.06 [0.86-1.3],0.603663295137606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FCN1,Ficolin-1,Inverse variance weighted,50,0.99 [0.97-1.02],0.606647595125578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.03 [0.92-1.16],0.606935690448518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COLEC12,Collectin-12,Inverse variance weighted,3,1.09 [0.79-1.51],0.608507011318529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,2,0.9 [0.6-1.35],0.608520089451723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,1.01 [0.97-1.05],0.609053056679805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CNTN5,Contactin-5,Inverse variance weighted,22,0.99 [0.94-1.04],0.609122199745397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.98 [0.9-1.07],0.611952094050359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.04 [0.9-1.19],0.612555929045951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,0.99 [0.94-1.04],0.614605084338857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.97 [0.88-1.08],0.614738240484174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.06 [0.83-1.36],0.616285789862072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.96 [0.81-1.13],0.616717862845363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NECTIN2,Nectin-2,Inverse variance weighted,3,0.94 [0.75-1.18],0.616827104601138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,0.96 [0.81-1.14],0.617067903412657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SMAD1,Mothers against decapentaplegic homolog 1,Wald ratio,1,1.08 [0.79-1.48],0.617491715783139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OSM,Oncostatin-M,Inverse variance weighted,6,0.98 [0.89-1.07],0.617910117583667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,6,1.02 [0.93-1.13],0.618398725764651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNAJC6,Putative tyrosine-protein phosphatase auxilin,Inverse variance weighted,5,0.97 [0.87-1.09],0.618914445639303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,1.03 [0.91-1.18],0.619094468883437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.08 [0.79-1.48],0.619115431161646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,14,1.02 [0.95-1.09],0.619661916895165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.03 [0.92-1.15],0.62175860099171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTN,Pleiotrophin,Inverse variance weighted,3,1.04 [0.9-1.2],0.6223958258807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PVR,Poliovirus receptor,Inverse variance weighted,3,0.91 [0.63-1.32],0.622752245593541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,0.91 [0.64-1.31],0.623452394274255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.98 [0.89-1.07],0.624228028373584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.12 [0.72-1.74],0.625026441147225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.97 [0.86-1.09],0.626987271450951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DSC2,Desmocollin-2,Inverse variance weighted,16,0.99 [0.95-1.03],0.627322282340328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.91 [0.63-1.32],0.627483262334312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.97 [0.86-1.1],0.629531541410098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.97 [0.88-1.08],0.631057147859135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.04 [0.89-1.21],0.632591935500751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.99 [0.97-1.02],0.635772453461752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.94 [0.72-1.23],0.638126180309328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.01 [0.98-1.03],0.642881624437108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP6,Gastrotropin,Inverse variance weighted,4,0.96 [0.83-1.12],0.644187465590131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MUC13,Mucin-13,Inverse variance weighted,3,0.92 [0.65-1.3],0.645190367059501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.06 [0.82-1.38],0.645590737787723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.94 [0.7-1.24],0.646216527174435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PPP3R1,Calcineurin subunit B type 1,Inverse variance weighted,3,1.04 [0.89-1.21],0.646290348298825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PALM2,Paralemmin-2,Inverse variance weighted,9,1.01 [0.96-1.07],0.649348020297703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,0.99 [0.94-1.04],0.64936333874694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,1.05 [0.85-1.29],0.650675945168014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.01 [0.96-1.06],0.651392998651777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.94 [0.72-1.23],0.652284082461679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PSME1,Proteasome activator complex subunit 1,Wald ratio,1,0.91 [0.61-1.36],0.653116092156941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,0.99 [0.94-1.04],0.65379662777215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,0.9 [0.56-1.43],0.654707550035783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,2,0.83 [0.36-1.89],0.65472668824194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NECTIN4,Nectin-4,Inverse variance weighted,4,1.04 [0.87-1.25],0.655050764805333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.95 [0.75-1.2],0.655568773294906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,1.06 [0.82-1.36],0.655859752498583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRISP3,Cysteine-rich secretory protein 3,Inverse variance weighted,65,0.99 [0.96-1.03],0.656281356737576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,26,0.99 [0.93-1.04],0.656687453763356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.02 [0.93-1.11],0.657271740992469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.04 [0.87-1.25],0.658892254587538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.02 [0.94-1.1],0.659291934523206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS9,Galectin-9,Inverse variance weighted,36,0.99 [0.96-1.03],0.660946694304702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.03 [0.89-1.2],0.661498719018597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.94 [0.71-1.24],0.661553902476504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.01 [0.98-1.04],0.664033314305618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1.07 [0.79-1.44],0.664766623881595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.03 [0.92-1.15],0.665316700902766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,UPB1,Beta-ureidopropionase,Wald ratio,1,1.19 [0.54-2.65],0.666394533268105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HJV,Hemojuvelin,Inverse variance weighted,2,0.87 [0.45-1.67],0.668007437513785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.97 [0.85-1.11],0.669162335754223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.06 [0.82-1.36],0.66925326739897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,1.01 [0.95-1.08],0.670049077408492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.02 [0.93-1.12],0.670531003102837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.03 [0.89-1.2],0.671823526356455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REN,Renin,Inverse variance weighted,8,0.96 [0.81-1.15],0.678160485174632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.97 [0.82-1.14],0.679272245672061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,A1BG,Alpha-1B-glycoprotein,Inverse variance weighted,4,1.05 [0.83-1.33],0.67940392948046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.98 [0.89-1.08],0.680472241676253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,UMOD,Uromodulin,Inverse variance weighted,34,0.99 [0.92-1.06],0.68065647858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.03 [0.89-1.19],0.682293963628562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.95 [0.74-1.22],0.683864600449533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.02 [0.94-1.1],0.685673682326606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.96 [0.79-1.17],0.686776998991041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,0.96 [0.78-1.18],0.690366728292222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PKD1,Polycystin-1,Inverse variance weighted,12,0.97 [0.85-1.11],0.692455506166856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RSPO3,R-spondin-3,Inverse variance weighted,5,0.95 [0.74-1.22],0.692860699700097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1 [0.98-1.03],0.692947793034065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EEF1D,Elongation factor 1-delta,Wald ratio,1,1.04 [0.84-1.29],0.692975933213279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.97-1.02],0.693328982649941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DCXR,L-xylulose reductase,Inverse variance weighted,9,1.05 [0.82-1.34],0.695543465484165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.01 [0.96-1.07],0.700692288200168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1.03 [0.87-1.23],0.700848471129585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.97 [0.84-1.13],0.704172488622974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.04 [0.86-1.24],0.707434210139152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,0.94 [0.66-1.32],0.708137688194423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PGF,Placenta growth factor,Inverse variance weighted,5,0.97 [0.82-1.15],0.708238318712037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDH1,Cadherin-1,Inverse variance weighted,16,0.99 [0.93-1.05],0.710869792938625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RTBDN,Retbindin,Inverse variance weighted,2,1.11 [0.62-1.99],0.713160525582957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.02 [0.91-1.14],0.713181217056703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.03 [0.89-1.18],0.715104607943336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,0.96 [0.79-1.18],0.716219786816123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.98 [0.9-1.07],0.716639435482448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.99 [0.95-1.03],0.719714338365682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.97 [0.82-1.15],0.721266698134792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.97 [0.82-1.15],0.723376462207979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1 [0.97-1.02],0.725191969320716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,0.95 [0.71-1.27],0.727052800030446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.11 [0.62-1.98],0.732936266665182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADA,Adenosine deaminase,Inverse variance weighted,22,1 [0.98-1.02],0.734053155730237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.97 [0.79-1.18],0.734192274451079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Wald ratio,1,1.06 [0.75-1.5],0.734963078212233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTSV,Cathepsin L2,Inverse variance weighted,34,0.99 [0.95-1.03],0.735968675021382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.02 [0.9-1.17],0.737824129061877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SNX15,Sorting nexin-15,Inverse variance weighted,3,0.95 [0.72-1.26],0.738903224627964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.98 [0.85-1.12],0.739817354159074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD36,Platelet glycoprotein 4,Inverse variance weighted,22,0.98 [0.87-1.11],0.740286366958366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,0.97 [0.84-1.13],0.741596197360369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,F9,Coagulation factor IX,Inverse variance weighted,3,0.97 [0.82-1.15],0.742298335981762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.98 [0.88-1.1],0.742630003621274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,1.02 [0.92-1.12],0.743982772514546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ALCAM,CD166 antigen,Inverse variance weighted,4,0.98 [0.86-1.12],0.746037929378343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.01 [0.96-1.06],0.748082648625245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.77 [0.16-3.74],0.748235424752302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.01 [0.95-1.08],0.748773306578943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HPSE,Heparanase,Inverse variance weighted,7,1.02 [0.9-1.16],0.74917258104007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CFP,Properdin,Inverse variance weighted,17,0.99 [0.95-1.04],0.751505521588828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.03 [0.86-1.22],0.752521397907186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.06 [0.73-1.55],0.754865717570723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.99 [0.96-1.03],0.755955897242405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.96-1.03],0.757481224088235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,39,1 [0.98-1.02],0.757832019736466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,0.97 [0.78-1.2],0.762785430822503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.03 [0.84-1.27],0.763145085884678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,1.02 [0.91-1.14],0.76452729285779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,Wald ratio,1,1.06 [0.73-1.54],0.7661367285116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.94 [0.64-1.39],0.766307890076493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,0.99 [0.94-1.05],0.767064553179832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,2,0.97 [0.78-1.2],0.770998889361809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,1.08 [0.66-1.76],0.771128264069493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CAPG,Macrophage-capping protein,Wald ratio,1,1.04 [0.81-1.34],0.772944396908304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MDK,Midkine,Inverse variance weighted,14,0.99 [0.92-1.06],0.77336001457264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD302,CD302 antigen,Inverse variance weighted,11,0.99 [0.91-1.07],0.77453193999326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,XG,Glycoprotein Xg,Inverse variance weighted,2,0.97 [0.77-1.22],0.775368700026534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SELL,L-selectin,Inverse variance weighted,11,1.02 [0.9-1.15],0.776440089964775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.02 [0.89-1.16],0.776641417516052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.98 [0.88-1.1],0.776644284405845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.01 [0.95-1.06],0.779688579221599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.99 [0.89-1.09],0.781808799056092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.01 [0.97-1.04],0.783704633866268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,0.98 [0.84-1.15],0.783912508290026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.97 [0.81-1.17],0.787632295620639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.01 [0.95-1.07],0.787795695376685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.97 [0.76-1.24],0.788190554413947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.96 [0.71-1.29],0.78876819233407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL18,Interleukin-18,Inverse variance weighted,26,0.99 [0.95-1.04],0.79071393579008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,0.99 [0.93-1.05],0.793049532876997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.99 [0.91-1.07],0.79473189094526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.04 [0.78-1.37],0.795714869221618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.01 [0.94-1.08],0.796909153361028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.02 [0.9-1.15],0.797692507613922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1.04 [0.77-1.4],0.799006005108846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,1.04 [0.77-1.39],0.799280350564759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,1.01 [0.91-1.14],0.799641592214976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.02 [0.85-1.23],0.800305797994894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.99 [0.96-1.03],0.801661310013343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.03 [0.81-1.32],0.802593363444795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.01 [0.92-1.12],0.802871730815347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.99 [0.91-1.08],0.803104232399869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.9 [0.4-2.03],0.80310542294757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.01 [0.9-1.14],0.803112102576669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EPPK1,Epiplakin,Inverse variance weighted,30,1 [0.97-1.02],0.80342313503592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MVK,Mevalonate kinase,Wald ratio,1,1.09 [0.55-2.15],0.804145130701221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Wald ratio,1,1.09 [0.55-2.15],0.804145130701221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TALDO1,Transaldolase,Wald ratio,1,1.09 [0.55-2.14],0.804145130701221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.98 [0.86-1.13],0.806497205809221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SRP14,Signal recognition particle 14 kDa protein,Inverse variance weighted,3,0.97 [0.79-1.21],0.80833263381405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1 [0.97-1.04],0.808464533922932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NOMO1,Nodal modulator 1,Inverse variance weighted,24,1 [0.97-1.02],0.809108674179579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.91 [0.41-2.01],0.811386491503403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,POF1B,Protein POF1B,Inverse variance weighted,4,1.01 [0.9-1.14],0.813456968011876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.98 [0.84-1.14],0.816953713978324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DCN,Decorin,Inverse variance weighted,2,1.06 [0.64-1.76],0.817242274239642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.02 [0.89-1.16],0.819081670946914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.99 [0.87-1.12],0.820284379346038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.01 [0.95-1.07],0.824846956566748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.98 [0.82-1.17],0.8248854056696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,1 [0.97-1.04],0.82506190927685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.99 [0.92-1.07],0.826015273251665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,1 [0.95-1.04],0.826367351091287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.97 [0.72-1.31],0.827146252362572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD7,T-cell antigen CD7,Inverse variance weighted,12,1 [0.97-1.02],0.828772013406323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNAJB1,DnaJ homolog subfamily B member 1,Inverse variance weighted,2,1.01 [0.89-1.15],0.829670699685712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.97 [0.77-1.23],0.830809691795463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,0.98 [0.83-1.16],0.830819945310432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.98 [0.83-1.17],0.831395987453741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.99 [0.91-1.08],0.834225825983901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CNTN1,Contactin-1,Inverse variance weighted,25,1.01 [0.95-1.06],0.83423607969755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LYN,Tyrosine-protein kinase Lyn,Inverse variance weighted,2,1.02 [0.83-1.26],0.834332361522837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ASS1,Argininosuccinate synthase,Inverse variance weighted,2,0.96 [0.68-1.37],0.834580352026654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ASAH1,Acid ceramidase,Inverse variance weighted,4,0.98 [0.81-1.19],0.837543564453086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.99 [0.9-1.09],0.838526420102435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,0.98 [0.82-1.18],0.839546835390069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.99 [0.93-1.06],0.842351856146651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CXCL8,Interleukin-8,Inverse variance weighted,8,0.99 [0.92-1.07],0.844910591799916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,1 [0.97-1.02],0.84561583934691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PTP4A3,Protein tyrosine phosphatase type IVA 3,Inverse variance weighted,6,0.99 [0.94-1.05],0.847905084532537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FAM3B,Protein FAM3B,Inverse variance weighted,26,1 [0.97-1.04],0.848890704013765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.01 [0.92-1.11],0.849007909998671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL16,Pro-interleukin-16,Inverse variance weighted,6,1.02 [0.82-1.28],0.849860825910173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.96 [0.64-1.45],0.852070982799654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FUOM,Fucose mutarotase,Inverse variance weighted,6,0.99 [0.87-1.13],0.852541971217174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1 [0.96-1.05],0.852645761985875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PYY,Peptide YY,Inverse variance weighted,16,1 [0.95-1.04],0.853198387825586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.99 [0.93-1.06],0.853751003624179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.02 [0.84-1.23],0.855363030441812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.03 [0.76-1.38],0.857205105497276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.98 [0.8-1.2],0.857587697058689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1 [0.95-1.06],0.860130760889405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,XCL1,Lymphotactin,Inverse variance weighted,15,1.01 [0.93-1.09],0.861020991362225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.02 [0.81-1.28],0.861182218483814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHGA,Chromogranin-A,Inverse variance weighted,5,1.01 [0.89-1.16],0.861555927268664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GCG,Pro-glucagon,Inverse variance weighted,2,0.98 [0.8-1.21],0.861872604262435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,1 [0.96-1.03],0.862205747718152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.99 [0.87-1.13],0.862698263697792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1 [0.96-1.04],0.863546653124446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.99 [0.91-1.08],0.868549289523802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,1.01 [0.9-1.14],0.868602832075686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGMN,Legumain,Inverse variance weighted,22,1.01 [0.89-1.14],0.870073097071953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.01 [0.93-1.09],0.871644773997186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SOST,Sclerostin,Inverse variance weighted,31,1 [0.95-1.06],0.873551437533704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGAM,Integrin alpha-M,Inverse variance weighted,12,0.99 [0.88-1.11],0.874682077883871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.98 [0.73-1.31],0.880181852905549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.99 [0.87-1.12],0.880439687289282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.99 [0.92-1.07],0.880504415117054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",Inverse variance weighted,2,1.01 [0.9-1.13],0.880971569267793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.01 [0.88-1.16],0.881283552406038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,1 [0.96-1.03],0.885756495750977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.99 [0.89-1.11],0.887711056596762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.01 [0.92-1.1],0.888452661686801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LEP,Leptin,Inverse variance weighted,4,0.97 [0.62-1.52],0.88922489942253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,1.01 [0.88-1.16],0.889580600625949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1 [0.99-1.02],0.891030775032018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.99 [0.88-1.12],0.89564393289449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DNPEP,Aspartyl aminopeptidase,Inverse variance weighted,4,0.99 [0.79-1.23],0.897209563489086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LATS1,Serine/threonine-protein kinase LATS1,Inverse variance weighted,4,0.99 [0.79-1.22],0.897910588954968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1 [0.95-1.05],0.899427422656229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.99 [0.85-1.15],0.89944034772944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,1 [0.94-1.08],0.89962236758736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MEP1A,Meprin A subunit alpha,Inverse variance weighted,28,1 [0.94-1.05],0.901143367190806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1 [0.95-1.06],0.901193848495653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1 [0.97-1.03],0.908050969394006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.99 [0.8-1.23],0.910607011330719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.01 [0.85-1.2],0.910948480347908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,24,1 [0.95-1.05],0.91521202690343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.01 [0.81-1.27],0.915760195553539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1 [0.91-1.09],0.916437785317915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.99 [0.89-1.11],0.917203110875811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1 [0.96-1.04],0.917689719983688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.94-1.06],0.919428001577191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.01 [0.86-1.19],0.921527994555123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,NUDT16,U8 snoRNA-decapping enzyme,Inverse variance weighted,4,0.99 [0.8-1.23],0.922784909508848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.01 [0.83-1.22],0.924766697256675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MBL2,Mannose-binding protein C,Inverse variance weighted,42,1 [0.98-1.02],0.925557841009374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADGRF5,Adhesion G protein-coupled receptor F5,Inverse variance weighted,16,1 [0.96-1.04],0.925843905032055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.99 [0.81-1.21],0.927451883471008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1 [0.92-1.09],0.928007433063966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,4,0.99 [0.84-1.18],0.929551335216615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.01 [0.86-1.18],0.930145611396561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TCTN3,Tectonic-3,Inverse variance weighted,44,1 [0.97-1.03],0.932132541663205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Wald ratio,1,0.99 [0.7-1.38],0.932502519218309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CEMIP2,Cell surface hyaluronidase,Inverse variance weighted,4,1 [0.91-1.09],0.933914116949847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.01 [0.82-1.25],0.935758261652491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL15,Interleukin-15,Inverse variance weighted,35,1 [0.96-1.04],0.936485495203309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHAD,Chondroadherin,Inverse variance weighted,15,1 [0.95-1.05],0.938006109469996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.96-1.04],0.938320775631515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANXA2,Annexin A2,Inverse variance weighted,2,1.02 [0.68-1.51],0.939104431383225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1 [0.92-1.08],0.940899409659489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1 [0.91-1.09],0.941394724834389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.99 [0.86-1.15],0.942254593596547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1 [0.95-1.05],0.942408608222297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.99 [0.8-1.24],0.948247804651424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1 [0.95-1.05],0.94901126094765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1 [0.89-1.13],0.94991322196962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,1 [0.92-1.08],0.95226117601531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GSN,Gelsolin,Inverse variance weighted,7,1 [0.89-1.12],0.952534040377743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OCLN,Occludin,Inverse variance weighted,2,1.01 [0.63-1.63],0.953342031358517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,HEXIM1,Protein HEXIM1,Inverse variance weighted,2,0.99 [0.79-1.24],0.954122330028542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1 [0.91-1.11],0.955347175687375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1 [0.92-1.09],0.956424424092025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.01 [0.8-1.26],0.958390453569544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.01 [0.76-1.33],0.958940929856532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1 [0.88-1.15],0.960485986853907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,TNR,Tenascin-R,Inverse variance weighted,19,1 [0.93-1.07],0.960753998384691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,1 [0.93-1.08],0.961017868383532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1 [0.94-1.06],0.961062339659955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,0.97 [0.31-3.09],0.961651890683018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SCG2,Secretogranin-2,Inverse variance weighted,2,1.01 [0.74-1.37],0.961996080158929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1 [0.94-1.07],0.9624818191735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1 [0.91-1.1],0.962772492464523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,1 [0.9-1.11],0.963879676388191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,1 [0.94-1.06],0.967315621155761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1 [0.91-1.1],0.967435275258883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PALM,Paralemmin-1,Inverse variance weighted,4,1 [0.87-1.16],0.970091739952529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1 [0.95-1.05],0.970504632450911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1 [0.83-1.19],0.970539488984541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,C19orf12,Protein C19orf12,Inverse variance weighted,3,1 [0.8-1.24],0.973370844935543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1 [0.89-1.13],0.973977806593365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1 [0.8-1.26],0.975786479822089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1 [0.95-1.05],0.976765455805686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1 [0.83-1.21],0.977793772189693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,IL10,Interleukin-10,Inverse variance weighted,4,1 [0.94-1.06],0.978101580362736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1 [0.89-1.12],0.978207821081595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ABL1,Tyrosine-protein kinase ABL1,Inverse variance weighted,3,1 [0.71-1.42],0.978816283950792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1 [0.96-1.04],0.978824519459021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1 [0.81-1.22],0.980818300176337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,1 [0.93-1.07],0.981479504416029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1 [0.88-1.14],0.982724352122953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PROC,Vitamin K-dependent protein C,Inverse variance weighted,40,1 [0.96-1.04],0.983911112192655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,CDH2,Cadherin-2,Inverse variance weighted,21,1 [0.88-1.14],0.985660011641287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1 [0.93-1.07],0.991971162457215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,DPY30,Protein dpy-30 homolog,Wald ratio,1,1 [0.76-1.32],0.992994294389343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SEPTIN8,Septin-8,Inverse variance weighted,4,1 [0.82-1.22],0.996476608393562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1 [0.92-1.09],0.997783952616672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,1 [0.53-1.88],0.998580099413131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,PI3,Elafin,Inverse variance weighted,18,1 [0.95-1.06],0.999573231011724,trans
